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ABSTRACT: 
When cutaneous mast cell tumors (MCT) are removed and evaluated for histopathology, 
the tissue undergoes many changes. Initially the mass is removed with planned surgical margins, 
which are a measure of grossly normal tissue around the tumor border. The cut margins are 
marked so that the pathologist can identify the margins in relation to the patient and the specimen 
is placed in formalin. Upon removal, however, the specimen undergoes noticeable shrinkage, 
which is further exacerbated by histologic processing. Upon being received by the laboratory, the 
gross appearance of the tissue has drastically changed from the time of surgery. This tissue is 
sectioned, stained and prepped for the pathologist to evaluate. Finally the pathologist prepares 
the histopathology report for the clinician. The histopathology reports, especially grade and 
margin reporting, are critically important for the clinician as they aid in the decision-making 
process regarding necessity and mode of adjunctive therapy recommended. However, the steps 
that occur from surgery until pathologic review can affect the pathologist’s ability to report 
accurate histologic margins if appropriate measures are not taken. Likewise, it is important for 
the surgeon to understand the tissue shrinkage that occurs if histologic and surgical margins are 
ever to be correlated. Therefore, the second project focused on evaluating MCT histopathology 
reports, which is the major communication tool between the pathologist and the surgeon. The 
specific objectives of the first project were to evaluate the effects of anatomic location, histologic 
processing, and sample size on shrinkage of surgically excised canine skin samples. The purpose 
of the second project was to describe and evaluate information presented within canine MCT 
histopathology reports specifically focusing on how information that is important for 
determining future treatment recommendations and patient prognosis is reported.  
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In the first project, elliptical samples of the skin, underlying subcutaneous fat, and muscle 
fascia were collected from the head, hind limb, and lumbar region of 15 canine cadavers. Two 
samples (10 mm and 30 mm) were collected at each anatomic location of each cadaver (one from 
the left side and the other from the right side). Measurements of length, width, depth, and surface 
area were collected prior to excision (P1) and after fixation in neutral-buffered 10% formalin for 
24 hours (P2). Length and width were also measured after histologic processing (P3).  
The results of the first project found that length and width decreased significantly at all 
anatomic locations and for both sample sizes at each processing stage. Hind limb samples had 
the greatest decrease in length, compared with results for samples obtained from other locations, 
across all processing stages for both sample sizes. The 30-mm samples had a greater percentage 
change in length and width between P1 and P2 than the 10-mm samples. Histologic processing 
(P2 to P3) had a greater effect on the percentage shrinkage of 10-mm samples. For all locations 
and both sample sizes, the percentage change between P1 and P3 ranged from 24.0% to 37.7% 
for length and 18.0% to 22.8% for width. Based on the results of this project we concluded that 
histologic processing, anatomic location, and sample size affected the degree of shrinkage of a 
canine skin sample from excision to histologic assessment. 
 In the second project, MCT histopathology reports were collected from medical and 
surgical oncologists in 4 geographic regions of the United States: Midwest, Northeast, South and 
West. Up to 15 reports were obtained for cases presenting to these clinics between January 1st 
2012 and May 31st, 2015. Inclusion criteria required that on the histopathology report the final 
diagnosis was MCT, a microscopic description was present, and the reports were from only cases 
where it was first attempt at surgical removal of the mass.   
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Three hundred and sixty-eight reports were collected from 26 contributors. While the 
majority of the reports contained a clinical history (85.9%), information to evaluate for 
prognostic indicators was lacking. Both Patnaik (Patnaik, Ehler, & MacEwen, 1984) and Kiupel 
(Kiupel et al., 2011) grading systems were described in 76.5% of reports with a single system 
being used in 7.1% and 15.2% of reports respectively. Subcutaneous MCT were assigned a 
grading scheme in 67.2% of reports with 33.3% stating appropriate limitations. Surgical margins 
were reported in 92% of the reports with 77.2% describing both deep and lateral margins. Tissue 
composing the deep margin was only described in 10.9% of the reports. Based on this project, it 
was concluded that reporting of MCT has variability across pathologists with inconsistencies 
present in the information provided for clinical history, the reporting of margin evaluation and 
grading of subcutaneous MCT. 
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CHAPTER 1 
INTRODUCTION  
When considering the treatment of cancer, there are 3 main pillars: surgical, medical, and 
radiation therapy. Surgery is the oldest of these pillars and surgical treatment of cancer in 
humans has been attempted for hundreds, potentially thousands of years. With the advent of 
antimicrobial and anesthetic drugs about 100 years ago, surgery became a viable treatment 
option and in the last 50 years incredible advances have been made in the control of various 
cancers through surgery and adjunctive therapies (Wyld, Audisio, & Poston, 2015).  
At first glance the concept of surgical oncology is duplicitously simple: physically excise 
the cancer. In application though, questions quickly arise. One of the first questions to be asked 
is what tissue needs to be removed? The short, simplified and debatable answer: all cancer cells. 
Which quickly prompts the second question, how can one determine the microscopic delineation 
between neoplastic and normal cells in the macroscopic world of surgery? For some benign 
tumors, this line in the sand correlates well with the gross borders of the mass. However, for 
other malignant tumors, such as sarcomas, tumor cells may continue well beyond what is visible 
to the naked eye. Thus, the concept of “safety margins” was born which is the idea of taking a 
margin of normal tissue around a mass in hopes of complete excision (Kope, Bastos, Filho, & 
Gouvea, 2005). The recommended size of this safety margin is based on the suspected biologic 
characteristics of the tumor as well as information gleaned from research on surgical outcomes. 
In the youth of surgical oncology, it was thought that bigger was better and the trend was 
towards aggressive surgery to obtain wide margins (Kooby & Maithel, 2016). As surgical 
techniques, knowledge of tumor biology, adjunctive therapies as well as imaging capabilities 
have increased, a shift towards the recommendation for more conservative margins has occurred 
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(Kooby & Maithel, 2016). Decreasing the amount of normal tissue removed can greatly decrease 
surgical morbidity especially for large tumors or tumors in close association with vital structures 
(Kooby & Maithel, 2016; Kope et al., 2005).  
In veterinary medicine, our understanding of margins in relation to specific tumor types is 
in its infancy. Mast cell tumors (MCT) are one of the most common cutaneous tumors and 
account for ~20% of all cutaneous tumors in canines (Garrett, 2014; London & Seguin, 2003). Its 
biologic behavior ranges from a benign lesion that is essentially cured with removal to an 
aggressive disease that can metastasize to the lymph nodes, spleen, liver, other abdominal organs 
and rarely lungs (London & Seguin, 2003). Histopathologic grading systems have been 
developed in an effort to help prognosticate the biologic behavior of the tumor based on 
histologic morphology. The two most common grading systems are the 2-tier system (high vs. 
low) by Kiupel et al. (2011) and the 3-tier system (1/low, 2/intermediate, 3/high) by Patnaik et al. 
(1984). Planned surgical and histologic margins have also been shown to be prognostic for MCT 
(Donnelly et al., 2015; Garrett, 2014; Mullins et al., 2006; Scarpa et al., 2012; Schultheiss, 
Gardiner, Rao, Olea-Popelka, & Tuohy, 2011; Seguin et al., 2006; Weisse, Shofer, & Sorenmo, 
2002). The commonly held dogma has been that MCT should be excised with 3cm lateral 
margins and 1 fascial plane deep. However, recent studies suggest that for benign lesions, this 
level of resection may be excessive (Donnelly et al., 2015). These concerns mirror the shift that 
has occurred in human medicine.  
Part of the difficulty in interpreting the current veterinary literature related to margins is 
the lack of standardization between study designs and variations in reporting of outcome 
measures. Some studies report outcome in relation to surgical margins, which are measured 
intra-operatively, while others describe outcome related to histologic margins. These 
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measurements are rarely equivalent especially for cutaneous tumors, such as MCT. The main 
cause of the discrepancy in measurements is related to shrinkage of the specimen that occurs 
after surgical excision (Becker, 2007). The phenomenon of shrinkage has been documented to a 
greater extent in humans and few studies have been performed in veterinary medicine. 
Understanding how shrinkage affects the relationship between surgical and histopathologic 
margins is important in order to be able to interpret the current literature on margins.  
Anecdotally, the description of margins within MCT histopathology reports is variable. 
Histopathology reports are an important communication between the pathologist and the 
clinician and are often used to guide decisions related to the necessity or type of adjunctive 
therapy recommended for a patient (Kamstock et al., 2011). Histopathology reports are also a 
common source of information for retrospective studies. Within the medical record, MCT 
histopathology reports are a potential source of several prognostic factors including tumor size, 
location, histologic diagnosis, grade, histologic margins and, if performed, cellular markers of 
proliferation such as c-kit and PCNA. Standardization of MCT histopathology reporting, 
especially in relation to variably reported margins, is necessary to improve communication as 
well as improve their use for retrospective studies.  
Related to histologic margins, there are several key points that should be included within 
the histopathology report (Kamstock et al., 2011). First, all histologic margins should be reported 
and the distance from the closest neoplastic cell to the margin should be given in metric units. 
Second, the tissue composing the margin should be described as some tissue types such as fascia 
are potentially more resistant to extension of tumor cells. Lastly, the terminology used to 
describe the histologic margins should not be subjective and terms such as close or narrow 
should be avoided. Ideally, all histopathology reports should list a mass as being incompletely or 
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completely excised. All of these recommendations greatly aid the clinician’s ability to make 
recommendations related to adjunctive therapy and improve the communication between the 
pathologist and the clinician.  
The overarching goal of this research was to add to the foundation of knowledge for 
understanding of the relationship between surgical and histopathologic margins in canine skin 
tumors, especially MCT. The objective of the first project was to evaluate effects of anatomic 
location, histologic processing, and sample size on shrinkage of excised canine skin samples. 
The objective of the second project was to describe and evaluate what information is presented 
within canine mast cell tumor (MCT) histopathology reports with a focus on the reporting of 
histologic margins.  
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CHAPTER 2 
LITERATURE REVIEW 
2.1 Concepts Affecting Margin Evaluation 
When reviewing the human literature, numerous articles can be found discussing margins 
in relation to a specific tumor type. However, these articles are sparse within the veterinary 
literature. Therefore, both human and veterinary articles have been included together within this 
review. Generally, within both the human and veterinary literature, articles are focused on 
reporting or reviewing margin recommendations that have been made based on studies 
evaluating various outcomes such survival time, recurrence rate and metastatic rate in relation to 
the surgical or histopathologic margins. Recently the Journal of Surgical Oncology released an 
issue that was focused on the impact of surgical margins on patient outcomes for common solid 
organ tumors in humans such as breast cancer. The editorial briefly touched on the importance of 
surgical margins and the concept that margin status is also affected by histologic assessment 
which has not been standardized (Kooby & Maithel, 2016). Glimpses and minor references to the 
general concepts and complications associated with margin evaluation are common; however, 
there are few articles that thoroughly summarize the topic (Becker, 2007; Kope et al., 2005; Kott, 
2008; Lurie, 2008).  
 
2.1.1 Safety Margins: 
Kope et al. attempted to review the literature on the concepts associated with “safety” 
margins. They discussed both macroscopic and microscopic safety margins with macroscopic 
safety margins being defined as the distance the surgeon plans to measure from the mass to the 
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cut edge (Kope et al., 2005). Microscopic safety margins are the distances measured from tumor 
cell to cut margin as determined by the pathologist (Kope et al., 2005).  
Related to macroscopic margins, the main concept that complicates the clinician’s ability 
to reliably use and define macroscopic margins is that the definition of the tumor margin is 
subjective and not reliable for infiltrative tumors (Kope et al., 2005). For some tumors, the 
visible/palpable margin correlates well with the distinction between normal and abnormal tissue 
while for other tumor types such as sarcoma, the neoplastic cells can extend beyond the visible 
margin of the tumor. In the case of cutaneous tumors, the properties of the skin can also 
complicate matters, as margin measurements will change depending on how much tension is 
placed on the skin. There are also other factors that could potentially affect the repeatability of 
macroscopic margin measurements and the execution of planned surgical margins in the patient. 
Measurements are sometimes made on surfaces that are irregular and may be difficult to measure 
accurately repeatedly. Another consideration is that the relative location of the tumor to other 
important anatomic structures (functional or aesthetic) may affect the clinician’s decision to 
follow published macroscopic margin recommendations (Kope et al., 2005). These alterations in 
plan during surgery may not be well documented and could be a source of error, especially in 
retrospective studies.  
The limitations of microscopic margins are related to changes that occur to the specimen 
after surgical excision, trimming methods, and the ability to distinguish normal cell from 
neoplastic cells (Becker, 2007). For example, in cutaneous tumors, translation of the tissue may 
make identifying the true cut margin difficult. In an effort to decrease error associated with this 
change, some clinicians mark the borders of the specimen with various inks or attempt to 
maintain the orientation the tissues with sutures or by pinning the sample to cardboard. 
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Inappropriate handling or rough transportation of a sample could result in loss of tissue from the 
periphery, resulting in a falsely positive margin or incomplete excision (Kope et al., 2005). The 
type of trimming method used by the laboratory can change the percentage of margins evaluated, 
which will be discussed in greater detail later in this chapter (Becker, 2007; Kamstock et al., 
2011). Another, critical step is the decision of which portion of the specimens to trim (Becker, 
2007; Kope et al., 2005). Related to certain tumors, such as MCT, the neoplastic cells can be 
difficult to distinguish from the normal populations of the cells within the tissue. Finally, how 
margins are reported on the histopathology report may affect treatment decisions or the ability to 
compare histologic margins to outcome.  
 
2.1.2 Positive versus Negative Margins:  
It is recommended that on histopathology reports margins be reported as incomplete 
versus complete and that the distance from the margin to the closest neoplastic cell be reported 
using metric measurements (Kamstock et al., 2011). Incomplete margins are defined as margins 
that have neoplastic cells touching the inked border (Kamstock et al., 2011). However, another 
paired terminology that commonly appears in the literature is positive and negative margins. For 
some, the terms positive and negative are synonymous with complete and incomplete, 
respectively. However, others use the terms positive and negative to include a certain width of 
normal tissue that has been defined within that respective paper or for a specific tumor type 
(Becker, 2007). Since the use of these terms is not standardized, one has to be careful when 
comparing outcomes across institutions in relation to positive and negative margins (Becker, 
2007). Similarly for some tumors, margins will be reported as close/narrow and a definition may 
be associated. For example, for head and neck tumors in humans a close margin has been sited as 
	   8	  
1-5mm while an involved margin was sited as <1mm (Sarode, Sarode, & Karmarkar, 2011). 
However, there is generally a lack of consensus on these definitions (Sarode et al., 2011). 
The basic concept behind incomplete/complete and positive/negative margins is that what 
is truly important to the patient is whether or not tumor cells have been left behind. Related to 
this idea some advocate sampling the “true margin” which is the tissue around the area of the 
resection or the tumor bed (Becker, 2007; Sarode et al., 2011). Possible methods for evaluating 
the true margin include shaving, and optical diagnostics such as microendoscopy and optical 
coherence tomography (Sarode et al., 2011). Evaluating the true margin via shaving maintains 
many of the sources of error present within classical margin evaluation such as surgeon sampling 
or pathologists evaluating a non-representative portion of the tissue causing false negative results 
(Becker, 2007).  
 
2.2 Specific Factors Affecting Margin Evaluation 
2.2.1 Tissue Shrinkage  
Numerous studies have been performed evaluating the phenomenon of post-operative 
surgical shrinkage in humans (Dauendorffer, Bastuji-Garin, Guero, Brousse, & Fraitag, 2009; 
Eid et al., 2007; El-Fol, Noman, Beheiri, Khalil, & Kamel, 2015; Gregory et al., 2003; Hudson-
Peacock, Matthews, & Lawrence, 1995; Johnson, Sigman, Funk, Robinson, & Hoffman, 1997; 
Kerns et al., 2008; Sarode & Sarode, 2012; Sarode et al., 2011; Schned et al., 1996; Silverman et 
al., 1992; Wang et al., 2004) and in non-human species (Clarke, Banks, & Findji, 2014; George, 
Hyde, Wilson, & Smith, 2013; Jeyakumar et al., 2015; Johnson et al., 1997; Reimer, Seguin, 
DeCock, Walsh, & Kass, 2005; Risselada, Mathews, & Griffith, 2015; Upchurch, Malenfant, 
Wignall, Ogden, & Saile, 2014). Tissues evaluated in human medicine include skin, cervix, 
	   9	  
intestine, rectum, prostate and oral mucosa. Studies on shrinkage have also been performed on 
various malignant cutaneous and mucosal tumors such as basal cell carcinoma, squamous cell 
carcinoma, and melanoma. In non-human species, shrinkage has been evaluated in the skin (dog 
and cat), oral mucosa (dog and pig) and intestine (dog). The only tumor type that has been 
specifically evaluated in relation to shrinkage is MCT (Risselada et al., 2015). 
Focusing on shrinkage of skin, for cutaneous neoplasms in humans the mean percent 
shrinkage has been documented to range between 14-31% (Blasdale, Charlton, Weatherhead, 
Ormond, & Lawrence, 2010; Golomb et al., 1991; Gregory et al., 2003; Hudson-Peacock et al., 
1995; Kerns et al., 2008; Silverman et al., 1992) with most studies reporting shrinkage to around 
20%. Likewise in one study the surgical defect enlarged by 25% (Gregory et al., 2003). When 
evaluating depth after surgical excision and formalin fixation, one report found that depth 
increased, decrease, or stayed the same in 31%, 56% and 10% respectively (Gregory et al., 
2003).  
For normal canine skin and for canine cutaneous neoplasms, the range of skin shrinkage 
for lateral margins has ranged from 10.2%-18.45% (Upchurch et al., 2014), 17.6-32% (Reimer et 
al., 2005) and 35-42% (Risselada et al., 2015). The mean shrinkage of labiobuccal mucosa was 
47.3% and the great portion of shrinkage was noted immediately after resection (Johnson et al., 
1997). Only one study has evaluated skin shrinkage in cats and found that the length decreased 
by 32.40%, width decreased by 34.21%, and depth increased by 54.95% (Jeyakumar et al., 
2015). In the canine, specimen thickness increased from 45.1-75.8% in one study (Reimer et al., 
2005). 
In humans, factors that have been implicated in affecting the degree of skin shrinkage 
include age (Golomb et al., 1991; Gregory et al., 2003; Silverman et al., 1992), location 
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(Dauendorffer et al., 2009; Gregory et al., 2003), tissue composition (Sarode & Sarode, 2012), 
tumor type (Blasdale et al., 2010; Hudson-Peacock et al., 1995) and method of resection (George 
et al., 2013; Smith, Hyde, & Wilson, 2008). However, the results of these studies have 
conflicting information and some state that age (Dauendorffer et al., 2009; Hudson-Peacock et 
al., 1995), location (Hudson-Peacock et al., 1995), and type of skin lesion (Dauendorffer et al., 
2009) did not have an effect on shrinkage. In one study scar tissue did not correlate with 
shrinkage after excision and formalin fixation, but the scars were noted to be superficial (Kerns 
et al., 2008). While sex is often evaluated in relation to shrinkage, the majority of studies 
evaluating shrinkage have not found sex to be associated with shrinkage (Dauendorffer et al., 
2009; Gregory et al., 2003; Hudson-Peacock et al., 1995).  
In studies on the effects of shrinkage of normal canine skin and skin with MCT, factors 
that have been evaluated include location (Reimer et al., 2005), the presence of MCT tumor, 
lines of skin tension and presence of a muscle or fascial layer (Reimer et al., 2005) and size of 
the sample (Upchurch et al., 2014). Reimer et al found site/location to affect the degree of 
shrinkage, while Upchurch et al. did not find any correlation between site, sample size, or 
measurement orientation in relation to lines of tension (Reimer et al., 2005; Upchurch et al., 
2014). The inclusion of a fascial layer did not have an effect on shrinkage, however, inclusion of 
muscle decreased the amount of shrinkage in length (17.6% vs. 26.6%) (Reimer et al., 2005). In 
contrast, in cats, inclusion of muscle on the thoracic samples had no effect on shrinkage 
(Jeyakumar et al., 2015).  
Likely, the main cause of skin shrinkage after excision is due to skin’s intrinsic tissue 
contractility (Kerns et al., 2008; Upchurch et al., 2014). In humans, skin looses tensile strength 
with age and the amount of shrinkage decreases by 0.3% for each year of age (Kerns et al., 
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2008). Another study did not correlate age to skin shrinkage but they did note that younger 
patients had greater contraction of the skin edges (Hudson-Peacock et al., 1995). Specific factors 
of skin composition may be the underlying cause for different degrees of margin shrinkage 
within the same tissue specimen includes varying levels of elastin or tumor cells, degree of 
keratinization, inflammation, and desmoplasia (Kerns et al., 2008; Sarode & Sarode, 2012). In a 
study evaluating shrinkage of tumor in relation to tumor free margins, the tumor had a lesser 
degree of shrinkage (11%) compared to the tumor free margin (19%) (Blasdale et al., 2010). 
These results lend further support that tissue composition plays an important role in shrinkage. 
No studies in veterinary medicine have evaluated tumor shrinkage in relation to margin 
shrinkage.  
 
2.2.1.1 Location:  
In humans, truncal tumors had proportionally 5% more shrinkage than head and neck 
tumors (Kerns et al., 2008) and others have also documented a increased amount of shrinkage in 
truncal tissue (Hudson-Peacock et al., 1995). Dauendorffer found that a greater shrinkage in 
length was noted in specimens taken from the limb (Dauendorffer et al., 2009). Also, in their 
study the truncal site initially appeared to affect shrinkage, but was no longer significant when of 
specimen size was taken into account (Dauendorffer et al., 2009). In some these papers it was 
suspected that some locations (i.e. head) are more susceptible to photodamage with resultant loss 
of elasticity that may contribute to a loss in the degree of skin shrinkage after excision and 
formalin fixation compared to truncal sites (Gregory et al., 2003; Kerns et al., 2008). Another 
study did not find location was associated with shrinkage (Golomb et al., 1991).  
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In canines, one study showed site was significantly associated with shrinkage with the 
amount of shrinkage being largest in the hind limb (a region over the tibia), intermediate in the 
thoracic region, and least on the head (Reimer et al., 2005). These variations in shrinkage were 
suspected to be due the inherent properties of the subepithelial tissue and that the organization of 
the myoepithelial structures in the skin (Reimer et al., 2005). Another ideas was that areas of the 
body placed under greater tension with movement would be more elastic and therefore have 
greater contraction when excised (Reimer et al., 2005). As previously stated, Upchurch et al. did 
not find location to effect shrinkage which contradicts these results. However, when skin 
shrinkage was evaluated in cats, the tissue over the region of the tibia had the greatest amount of 
shrinkage (similar to the results of Reimer et al.) (Jeyakumar et al., 2015). While the Upchurch et 
al. and Reimer et al, both evaluated samples from the hind limb as well as thorax and head, 
possible reasons Upchruch et al. proposed for the discrepancy in findings included differences in 
sample excision technique, sample shape, breed, and live animals versus cadavers (Reimer et al., 
2005; Upchurch et al., 2014).  
 
2.2.1.2 Formalin Fixation:  
The effects of formalin fixation may be tissue dependent. An MRI study was performed 
that evaluated formalin fixation on porcine limbs that were either whole or cross-sectioned into 
2cm thick slices (Docquier et al., 2010). They found that the volume of fatty tissue shrunk by 4% 
(whole) and 9% (cross-sectioned) (Docquier et al., 2010). While muscle increased by 4-5% 
(whole) and 3% (cross-section) and formalin fixation had no effect on bone (Docquier et al., 
2010). The study also showed that positioning effected the width/height of the whole samples, 
while the cross-sectioned samples which were placed flat had no overall change in width or 
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height(Docquier et al., 2010). Based on the MRI, gravity appeared to cause sagging of the 
muscle relative to the bone (Docquier et al., 2010).  
Several studies have specifically evaluated the effect of formalin fixation on cutaneous 
tissue in humans (Dauendorffer et al., 2009; Golomb et al., 1991; Hudson-Peacock et al., 1995; 
Kerns et al., 2008). In a prospective study by Kerns et al. cutaneous lesions were excised and 
measured prior to excision, immediately after excision, and then 24 hours after formalin fixation. 
They found that significant shrinkage occurred after excision with the percent change in length 
being 23% and width being 14.6% (Kerns et al., 2008). Formalin fixation resulted in minor 
expansion of the samples (-3.6% length and -4.7% width). Other studies have also concluded that 
formalin is relatively non-contributory to cutaneous tissue shrinkage, with Dauendorffer et al. 
reporting that no difference in measurements after excision and formalin fixation being observed. 
(Dauendorffer et al., 2009; Golomb et al., 1991). However, there have been studies that found 
formalin did have a large effect on shrinkage. One study found that excision caused a 22% 
shrinkage while formalin fixation caused and additional 11% fixation (Hudson-Peacock et al., 
1995). 
For canines, only one study has specifically reported on the affects of formalin fixation 
on the degree of shrinkage in skin. Upchurch et al. reported that diameter measured immediately 
after excision and then formalin fixation did not change significantly with the overall percent 
changed being 1.69% (Upchurch et al., 2014). Reimer et al, performed the measurements 
necessary to assess the effects of formalin fixation but these measures were not specifically 
reported or discussed (Reimer et al., 2005). In a shrinkage study for feline skin (Jeyakumar et al., 
2015), the effects of formalin fixation were not discussed, however, based on their results from 
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the time of excision until post-formalin fixation the median percent shrinkage for all 
locations/measurements was 3.9% (range -7.1-15.1%). 
 
2.2.1.3 Method of Excision: 
The type of instrument/method used to excise tissue may also have an effect on 
shrinkage. Shrinkage was evaluated in porcine lingual mucosa using cutting diathermy, 
coagulation diathermy, harmonic scalpel and a scalpel blade (Smith et al., 2008). They found that 
lesions excised with cutting or coagulation diathermy had less shrinkage compared to tissue 
excised with the harmonic scalpel or standard scalpel blade (George et al., 2013; Smith et al., 
2008). It was theorized that the diathermy cause thermal damage and denaturation of the muscle 
which resulted in a decrease in contracture (George et al., 2013). Hudson-Peacock et al. noted 
that wound area decreased in size post-diathermy (Hudson-Peacock et al., 1995).  
 
2.2.1.4 Relating Histologic Margins to Surgical Margins: 
 Many methods have been developed to evaluate shrinkage in an attempt to equate 
histologic margins to surgical margins. For basal cell carcinoma, a microscopic method was 
developed to measure shrinkage (Sarode & Sarode, 2012). The proposed advantages of this 
method were that it allowed the shrinkage of individual margins to be evaluated as well as was 
more accurate than macroscopic methods (Sarode & Sarode, 2012). Silverman et al. developed a 
formula to calculate surgical margins from histologic margins for melanoma. They found that 
86.5% - 90.8% (depending on population used) of the specimens could have the surgical margins 
calculated to within +/-3.5mm from the histologic margins (Silverman et al., 1992). These types 
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of formulas are likely only useful for the specific populations they were derived for, in this case, 
human cutaneous melanoma for specific age groups.  
 Some advocate the margin guidelines should be shrinkage based, meaning the percent 
shrinkage should be calculated for each specimen (Sarode et al., 2011). As part of this 
recommendation, it was stated that histopathology reports should designate the distance of 
neoplastic cells from the deep and lateral cut edges (Sarode et al., 2011). In human medicine, 
accounting for shrinkage is not only useful when attempting to compare research studies but also 
has financial implications as it is a source of downcoding (Dauendorffer et al., 2009; Gregory et 
al., 2003). In this situation, downcoding is a term used to designate when costs related to surgical 
removal and evaluation of mass have been decreased inappropriately as cost is based on size. 
Since masses tend to decrease in size after excision and histologic processing, this is a potential 
source for financial loss for the providers.  
 
2.2.2 Margin Marking 
There are 3 benefits of marking margins with ink or sutures. 1) The marked margin 
defines the sample in relation to patient (Kamstock et al., 2011). 2) It visibly identifies all cut 
margins (Kamstock et al., 2011). 3) The marks can be used to denote an area of greatest concern 
(Kamstock et al., 2011). Other general guidelines that were listed by Kamstock et. al. for 
appropriately inking tissues included the following: 1) Recommend inking prior to formalin 
fixation as artifacts such as translation may alter the true margin. 2) Use official surgical ink or 
waterproof drawing ink to avoid loss of staining. 3) Blot tissue dry prior to inking. 4) Mark the 
margins with an object rather than dipping the specimen. 5) Allow ink to dry for 5-10 minutes 
prior to fixation. 6) Do not cut the specimen until all these steps have been performed. 7) The 
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best ink colors to use are black, yellow and green as they are easily seen against H&E stain. 
Also, if second margins are taken such as in the case of shaving, the orientation needs to be 
appropriately identified.  
 
2.2.3 Tissue Trimming and Evaluation 
Various trimming methods reported include cross-sectioning (i.e. radial method which 
uses perpendicular sectioning), breadloafing (i.e. parallel sections at regular intervals), modified 
technique that combines parallel and radial techniques, and tangential sections (shaved edges) 
(Kamstock et al., 2011). For cutaneous neoplasms, the margin can be evaluated either by 
perpendicular or parallel sectioning. Parallel sections (i.e. shave) of the margin allow a larger 
portion of the margin to be assessed for the presence of neoplastic cells, however they cannot 
determine the distance from the closest neoplastic cell to the margin (Lurie, 2008). Conversely, 
perpendicular sectioning allows the distance from the tumor to the margin to be measured but 
only represents a minor portion of the overall margin (Lurie, 2008). Perpendicular section is 
generally what’s performed during radial sectioning and is commonly used for small and 
moderate sized masses. The disadvantages of radial sectioning are that this technique assumes 
symmetrical growth of the tumor when evaluating margins and only a very small portion of the 
tissue is being evaluated (<0.1%) (Kamstock et al., 2011). In the tangential technique multiple 2-
3mm sections are shaved off the margin in a parallel fashion and any tumor cells noted within 
the shaved section make that margin incomplete (Kamstock et al., 2011) and has the 
disadvantages associated with parallel sections.  
 Often, a standard margin evaluation is generally performed unless otherwise requested by 
the surgeon. Without the surgeon specifically stating what they considered to be important areas 
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of evaluation, the most ideal positioning for transecting may not be performed (Kope et al., 
2005). Likewise, the sectioning of the samples may be performed by non-pathologists and thus 
may not be as qualified to pick the best positioning for trimming (Kope et al., 2005). Both of 
these factors could potentially result in reporting of falsely complete margins.  
 
2.2.4 Margin Reporting 
Related to margin reporting, Kamstock et al. recommended that all histopathology reports 
include following: gross description/picture, diagnosis, microscopic description, comments 
section and references (Kamstock et al., 2011). Within each of these sections they made specific 
recommendations. For diagnosis, it was recommended that the grade should follow if applicable. 
Likewise if the clinician asked for a grade and one did not exist or wasn’t created specifically for 
that tumor type, then a statement of limitation should be given. Also, the microscopic description 
should include all the findings that were used to derive that grade. For, MI it should be given as 
the number of mitotic figures per high powered field (400x) with ideally 10 fields with the 
highest activity being evaluated.  
Related to margins, all the following should be included in the histopathology report 
(Kamstock et al., 2011): 1) method of specimen trimming, 2) description of cells closest to the 
margin, 3) an objective measurement of the margins and 4) a description of the tissue composing 
the margin. Kope et al. stated that they believe there may be a misunderstanding in the meaning 
of “free surgical margins” (Kope et al., 2005). This statement highlights 2 separate concepts 
related to margin reporting: 1) Factors previously discussed such as the biologic behavior of the 
tumor, post-operative tissue handling, tissue trimming, etc. can affect the pathologist ability to 
determine if tumor excision is complete. This is an idea that needs to be kept in mind when 
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reading the histopathology report. 2) The use of subjective description of margins can leave 
room interpretation and should be avoided (Kamstock et al., 2011). As previously discussed for 
positive vs. negative margins, the use of subjective terminology needs to be avoided (Kamstock 
et al., 2011).  
The recommendations discussed in the section on margin marking should also be applied 
in this section as errors in inking can effect margin reporting. Possible reasons for falsely 
positive margins include separation of the tissue, lack of identified cut borders, translation and 
inability for the pathologist to definitively state complete or incomplete margins due lack of 
tissue or issues related to trimming (Kope et al., 2005). While the most likely reason for a falsely 
negative margin is related to the fact that in most cases only a small portion of the cut margin is 
evaluated and tumor growth is often asymmetrical (Kope et al., 2005).  
 
2.3 Other Methods of Margin Evaluation  
2.3.1. Mohs Micrographic Surgery:  
 In Mohs micrographic surgery (MMS), the surgeon, technician and pathologist may be 
(and ideally are) the same person (Kope et al., 2005). In this method of margin evaluation shaved 
sections are taken through the parallel and deep margins of the tumor (Lurie, 2008). The shave 
sections are meticulously labeled in relation to the to the tumor bed. The surgeon/pathologist 
immediately processes (inking and frozen section) and evaluates the sections while the patient 
waits. Further sections are then taken of any of the incomplete margins, essentially following the 
path of the tumor. The Mohs technique is most commonly used in the treatment of melanoma 
(Lurie, 2008)and basal cell carcinoma in humans. The advantages of this technique are that is 
allows for the minimal amount of healthy tissue to be removed while also helping to ensure 
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complete resection of the mass. Disadvantages include the process requires very specialized 
training, is time consuming and is only practical for relatively small tumors.  
 Mohs micrographic surgery has been reported for management of periocular mast cell 
tumor in a dog (case report) (Bernstein, Storey, & Bauer, 2013). The possible indications for 
MMS include: tumors with poorly defined local invasion, anatomic locations with greater 
subclinical invasion, locations that require tissue conservation and known perineural invasion 
(Bernstein et al., 2013).  
 
2.3.2 Shave Technique: 
The underlying concept of shaving in breast cancer is similar to the Mohs technique 
except modified for use with a larger tumor. Shaving is generally performed around the resection 
cavity and the number of shaved sections is variable. Because of the larger size of these masses, 
if intraoperative evaluation is performed only one frozen section perpendicular to the margin is 
evaluated (Lurie, 2008). The location of the section to be cut is generally chosen off of gross 
evaluation of the mass (Lurie, 2008) and has the same limitations as radial sectioning. 
Unsurprisingly, falsely negative complete margins are not infrequent (Lurie, 2008). Additional 
shaved margins are taken as deemed necessary by the surgeon. Like with the Mohs technique, 
inking and orienting the shaved sections in relation to the tumor bed is important. After standard 
formalin fixation and processing, the margins are evaluated, however the method of margin 
evaluation is not standardized (Lurie, 2008).  
2.3.3 Intraoperative Surgical field Imaging:  
Various modalities are being studied and used in human medicine to evaluate the wound 
bed or the “true margin” including: optical coherence tomography, radiofrequency spectroscopy, 
	   20	  
Raman spectroscopy, positron emission tomography probes and near-infrared fluorescence 
optical imaging (Liptak, 2013). None of these modalities are currently standard of care in 
veterinary medicine. However, near-infrared fluorescence optical imaging has been used in 
research studies in veterinary medicine (Iida et al., 2013) and may gain more widespread use a 
promising technique for further evaluating margins in companion animals (Liptak, 2013).  
 
2.4 Margin Evaluation and Reporting for MCT 
2.4.1 General Information 
Mast cell tumor (MCT) is one of the most common cutaneous tumors in the canine with 
reports ranging its frequency between 7-21% (Withrow & Vail, 2007). Its biologic behavior is 
variable and has been associated with multiple prognostic factors including: presence of clinical 
signs(Mullins et al., 2006), tumor location (Garrett, 2014; Gieger et al., 2003; Kiupel, Webster, 
Miller, & Kaneene, 2005), number of concurrent tumors (Kiupel et al., 2005), stage (Garrett, 
2014) and tumor size (Mullins et al., 2006), mitotic index (MI) (Berlato et al., 2015; Elston, 
Sueiro, Cavalcanti, & Metze, 2009; Garrett, 2014; Romansik, Reilly, Kass, Moore, & London, 
2007; van Lelyveld et al., 2015), histologic grade (Donnelly et al., 2015; Garrett, 2014; Kiupel et 
al., 2011; Murphy, Sparkes, Smith, Blunden, & Brearley, 2004; Patnaik et al., 1984; Sabattini, 
Scarpa, Berlato, & Bettini, 2015; Stefanello et al., 2015; Takeuchi et al., 2013), histologic 
margins (Donnelly et al., 2015; Garrett, 2014; Mullins et al., 2006; Scarpa et al., 2012; 
Schultheiss et al., 2011; Seguin et al., 2006; Weisse et al., 2002) and various cellular markers 
(Berlato et al., 2015; Costa Casagrande et al., 2015; Garrett, 2014; Kandefer-Gola et al., 2015; 
Maglennon et al., 2008; Scase et al., 2006; Seguin et al., 2006; Takeuchi et al., 2013; van 
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Lelyveld et al., 2015; Vascellari et al., 2013; Webster, Yuzbasiyan-Gurkan, Miller, Kaneene, & 
Kiupel, 2007).  
The most common method of diagnosis for MCTs is through fine needle aspiration; but 
only recently a current method has been documented to predict grade based off of cytological 
samples. The 2 studies that have been published attempting to predict grade based on cytology 
have shown promising results, but are not commonly used in the clinical setting (Camus et al., 
2016; Scarpa, Sabattini, & Bettini, 2014). Established grading methods currently applied to MCT 
are based on histopathology samples. Currently there are 2 common methods for grading MCT: 
the 2-tier method (Kiupel et al., 2011) and the 3-tier method (Patnaik et al., 1984) which are 
described in greater detail later within this chapter. Low grade tumors that are completely 
excised generally do not require further treatment, while adjunctive therapies are often 
recommended if there are incomplete margins or metastatic disease (Donnelly et al., 2015). 
However, the lack of standardization in the research studies related to the use of MCT grading 
systems and the cut off values for complete margins make comparisons across studies difficult.  
Mast cell tumors have been reported to metastasize to local lymph nodes, lungs, spleen, 
liver and bone marrow (Withrow & Vail, 2007). Therefore, possible staging modalities that may 
be considered include local lymph node fine needle aspirates, thoracic radiographs or CT, and 
abdominal US or CT. Depending on the results of the imaging and clinician preference, fine 
needle aspirates of the spleen or liver may also be considered. However, it’s important to note 
that the ultrasonographic appearance of the liver/spleen can appear normal in the face of 
metastatic disease or abnormal in appearance without the presence of disease. However, 
detection of metastatic disease within a draining lymph node is strongly correlated with 
prognosis; one study documented that distant metastatic disease was only noted in dogs that had 
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local metastasis to the region lymph node (Warland, Amores-Fuster, Newbury, Brearley, & 
Dobson, 2014). The same study also found that none of the dogs had visible metastatic disease 
on thoracic radiographs calling into question the utility of this diagnostic test. Instead they 
suggested that staging initially rely on assessment of the regional lymph nodes for the presence 
of disease (Warland et al., 2014). Rates of distant metastatic disease have been reported as 6.8% 
(Warland et al., 2014), while rates of local metastatic disease have been reported as 30.9% 
(Warland et al., 2014).  
In addition to grade and margins, overall survival time is effected by presence of 
metastatic disease and various markers of proliferation such as c-KIT, AgNOR and PCNA 
(Berlato et al., 2015; Costa Casagrande et al., 2015; Garrett, 2014; Kandefer-Gola et al., 2015; 
Maglennon et al., 2008; Scase et al., 2006; Seguin et al., 2006; Takeuchi et al., 2013; van 
Lelyveld et al., 2015; Vascellari et al., 2013; Webster et al., 2007). The location of metastatic 
disease also effects survival as dogs that have metastatic MCT within the bone marrow have a 
shorter median survival time of 43 days with a range of 14-57 days (Marconato et al., 2008).  
 
2.4.2 Histopathology and Grading 
 One of the first papers that attempted to correlate histologic findings (grade) to biologic 
behavior was written by Bostock in 1973 (Bostock, 1973). This grading system published in this 
paper was modified into the Patnaik system published in 1984 (Patnaik et al., 1984). The Patnaik 
system is a 3-tier system grading MCT as grade 1, grade 2, and grade 3. Generally grade 1 
tumors are considered well differentiated and confined to the interfollicular dermis. Grade 2 
tumors are intermediately differentiated and extend into the deep dermis/subcutaneous tissue 
while grade 3 tumors are poorly differentiated with infiltration (Patnaik et al., 1984). Specific 
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histologic features that are used to determine the grades are the following: location, cell 
morphology, nuclear morphology, architecture, cellularity, stromal reaction, mitotic figures, 
edema and necrosis (Northrup et al., 2005; Patnaik et al., 1984). The 3-tiered system has been 
shown to prognostic when evaluating grade 3 tumors versus grade 1 & 2 tumors. In a study of 
340 cutaneous MCT, grade 3 tumors had a median survival time of 278 days, versus over 1300 
days for grade 1 & 2 tumors (Murphy et al., 2004). In the same study recurrence was found in 
19% of grade 3 tumors and 6% of grade 2 tumors. Other studies have reported recurrence rates 
for grade 2 MCT to by between 4-21% (Scarpa et al., 2012; Schultheiss et al., 2011; Weisse et 
al., 2002) while for grade 3 and high grade tumors the recurrence rate was 36% (Donnelly et al., 
2015). For grade 3 tumors, lymph node status was consistently associated with outcome and 
metastatic disease generally was found to be the cause treatment failure (Donnelly et al., 2015; 
Hume et al., 2011). This study also reported the overall survival time to 257 days which similar 
to Murphy et al.  
Multiple studies have shown that grade 2 tumors can have a variable behavior and there 
appears to a subpopulation that behaves like high-grade tumors (Murphy et al., 2004; Stefanello 
et al., 2015). Furthermore, one of the main criticisms of the Patnaik grading system is that 
majority of MCT are classified as grade 2. In a study of 100 dogs, only 22% and 4.3% had grade 
and 1 and 3 MCT respectively while 74% had grade 2 MCT (Schultheiss et al., 2011). The 
guidelines used to grade under the Patniak system are subjective. In one study, grade 3 tumors 
only had a 75% concordance and grade 1 & 2 tumors had a 63% concordance (Kiupel et al., 
2011). Because of this subjectivity and potentially the pathologist’s reluctance to pick a side, 
many the majority are classified as grade 2 diminishing the prognostic value of this grading 
system (Northrup et al., 2005; Sabattini et al., 2015).  
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 In an attempt to overcome the deficiencies of the Patnaik system, the 2-tiered system was 
developed (Kiupel et al., 2011). In this system, tumors are either classified as low grade or high 
grade, which eliminates the option for indecision. This system is also less subjective as a MCT is 
considered high grade if it has any one of the following characteristics: 1) ≥7 mitotic figures/hpf, 
2) ≥3 multinucleated giant cells, 3) ≥3 bizarre nuclei or 4) karyomegaly in 10% of cells(Kiupel et 
al., 2011). However, karyomegaly and bizarre nuclei can still be subjective measures. The 2-
tiered system has been shown to be prognostic with high grade tumors having a 4 month survival 
time. It has also been shown to have 97% consistency between observers (Kiupel et al., 2011). 
Low grade tumors also have a low risk (4%) of local recurrence (Donnelly et al., 2015). It has 
also been shown that the 2-tiered system can potentially identify the biologically more 
aggressive tumors that are classified as grade 2 on the 3-tiered system (Donnelly et al., 2015).  
When it comes to histologic reporting of MCT, it has previously been recommended to 
use both systems ("VCS Oncology-Pathology Working Group MCT Subgroup Consensus on 
Grading Canine Cutaneous MCT," 2013) as each has potential strengths/weaknesses and each 
have been associated with prognosis (Donnelly et al., 2015; Kiupel et al., 2011; Murphy et al., 
2004; Patnaik et al., 1984; Schultheiss et al., 2011; Stefanello et al., 2015; Takeuchi et al., 2013). 
However, recently studies have been published comparing both grading systems (Sabattini et al., 
2015; Stefanello et al., 2015; Takeuchi et al., 2013). Both Sabattini et al. and Takeuchi et al. 
evaluated the grading systems in relation to survival and both concluded the Kiupel system had 
superior prognostic value. Stefanello et al. evaluated the grading systems for prognosticating 
metastatic disease and concluded prognostication should not rely solely on grade but factor in the 
results of staging as both grade 1/2 and low grade tumors had metastatic disease (5.8%/16.5% 
and 14.9% respectively).  
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 Mitotic index is used as one of the criteria for the 2-tiered grading system; however, MI 
has been shown to be prognostic in its own right. Mitotic index has been shown to correlate with 
grade and survival (Romansik et al., 2007). A MI ≤5 had a median survival time of 70 months, 
compared to 2 months (all grades) or 5 months (grade 2) (Romansik et al., 2007). It was also 
shown that dogs with grade 3 tumors and MI ≤5 did not reach median survival time (Romansik 
et al., 2007) suggesting that is one of the key factors in the 2-tiered Kiupel system’s ability to 
distinguish biologically aggressive tumors. Other studies have evaluated MI and Ki67 in relation 
to survival (Berlato et al., 2015; van Lelyveld et al., 2015). Mitotic index >5 was had poor 
sensitivity (32.4%) but good specificity (96%) as a predictor of death, while generally the inverse 
was true for Ki-67 (van Lelyveld et al., 2015). Another study used a different stratification for 
MI with MI>7, MI 1-7 and MI <1 and found that median survival time was 3 months, 15 months 
and not reached respectively (Elston et al., 2009).  
 
2.4.3 Margins 
Multiple studies have been performed attempting to correlate histologic and planned 
surgical margins of MCT to prognosis (Donnelly et al., 2015; Garrett, 2014; Mullins et al., 2006; 
Scarpa et al., 2012; Schultheiss et al., 2011; Seguin et al., 2006; Weisse et al., 2002). While it 
can be agreed that patients with complete margins have a better prognosis than patients with 
incomplete margins, the safety margin (histologic or surgical) necessary to obtain complete 
margins is still being debated. Classically it has been recommend that MCT be excised with 3cm 
lateral margins and 1 fascial plane deep. However, the evidence to support this recommendation 
is lacking especially for low grade tumors. Simpson et al. prospectively evaluated 1cm, 2cm, and 
3cm planned surgical margins and found that all grade 1 MCT and 75% of grade 2 MCT were 
	   26	  
complete excised with 1cm, while all grade 2 MCT were complete excised with 2cm surgical 
margins (Simpson et al., 2004). Based on this study it was suggested at 2cm margins and 1 
fascial plane deep should be sufficient for grade 1 & 2 MCT (Simpson et al., 2004). Fulcher et al. 
excised 23 MCT using these recommendations and had complete margins in all but tumors. No 
local recurrence was noted and the survival time was never reached (> than 538 days). Another 
study found that low grade tumors with histologically tumor free margins less than 3mm did not 
recur and that high grade tumors had significant risk of local recurrence regardless of histologic 
tumor free margin width (Donnelly et al., 2015).  
These studies highlight the difficulty in comparing results and recommendations related 
to margins and outcome. For example, while the Donnelly study suggests that 3mm may be 
sufficient margin, they are referring to histologic margin, which can’t be correlated back to 
surgical margins. The Simpson et al. study reported outcome in planned surgical margins related 
to histologic margins, however this study had relatively few dogs and there are potential factors 
that could have skewed their results such as tissue loss and measurement errors secondary to 
histologic processing. Also all dogs in the Fulcher and Simpson et al. studies were grade 1 and 2 
MCT. Also, error associated with defining the border of the MCT could affect the results as the 
intraoperative determination of margins can be difficult if excessive edema formation from 
spontaneous cytokine release occurs (Matz, 2015) or if the borders of the tumor are irregular. 
Currently, there is no standardization in histologic reporting for what is considered a 
complete or “clean” margin. Many studies report the use of 1-2mm (Pratschke, Atherton, Sillito, 
& Lamm, 2013; Thompson et al., 2011; Weisse et al., 2002) away from the margin as considered 
clean, however some require at least 5 or 9 mm of normal tissue between the margin and 
neoplastic cells (Kry & Boston, 2014; Murphy et al., 2004).  
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A method of surgical margin determination for MCT has been proposed that is based on 
dimension of the tumor and proportional margins (Pratschke et al., 2013). In this system, the 
measurement of the lateral surgical margins was based on the largest diameter of the mass 
(maximum of 4cm) while keeping the deep margin as one fascial plane deep. Using this 
approach 85% of the tumors had a histologically complete resection (Pratschke et al., 2013). One 
of the major limitations of this study however were that the majority of the tumors were low 
grade (90% based on the Kiupel system), therefore while only 1 dog was suspected to have 
progression of disease, this may not reflex a normal population of MCT. 
 
2.4.4 MCT and recurrence 
 Despite the presence of incomplete margins, grade 2 MCT often do not recur with a 
23.3% recurrence rate being reported (Seguin et al., 2006). Lack of recurrence with positive 
margins may be related to a falsely positive margin due to the presence of non-neoplastic mast 
cells (Becker, 2007; Kope et al., 2005). However, in a study evaluating outcome of dogs with 
either incomplete excision or “close” margins that underwent additional adjunctive therapy (re-
excision or radiation), it was found that survival time was improved compared to dogs that did 
not receive additional treatment (Kry & Boston, 2014). In that study, median survival times for 
dogs with re-excision or radiation was 2930 days and 2194 days respectively while in the 
untreated group survival time was 710 days (Kry & Boston, 2014). This data may suggest that 
while some dogs may be false positives, some could be truly incomplete resections.  
Possible reasons for tumor recurrence in the face of supposedly complete margins include 
the previously mentioned possibility of erroneous sampling or margin evaluation. However, a 
more interesting possibility is the concept of field cancerization, which is the idea that the cancer 
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changes the microenvironment around the tumor, predisposing the cells in close association to 
the tumor to become cancerous (Becker, 2007). Another possibility relatively unique to MCT is 
that since MCT produce chemotactic factors, it can be difficult to tell if the mast cells near the 
margins are neoplastic cells, if they are secondary to local inflammation or if they are local mast 
cells that are naturally present (Fulcher et al., 2006; Gieger et al., 2003; Kry & Boston, 2014).  
 
2.4.5 Subcutaneous and other Non-Cutaneous MCT 
It has been recommended that the standard grading systems designed for cutaneous MCT 
should not be applied to subcutaneous/non-cutaneous MCT as they demonstrate different 
biologic behaviors (Elliott et al., 2016; Newman, Mrkonjich, Walker, & Rohrbach, 2007; 
Thompson et al., 2011). Generally subcutaneous MCT are considered to a more benign biologic 
behavior than their cutaneous counterparts. Thompson et al. reported that the median survival 
time was unable to be reached and the probability of survival was 95%, 93%, 92% and 86% at 6 
months, 1 year, 2 years, and 5 years respectively (Thompson et al., 2011). Also, only a 4% 
metastatic and 8% local recurrence rate was present in spite of the fact that 56% had incomplete 
resections (Thompson et al., 2011).  
The primary grading systems used for grading MCT were specifically developed for 
cutaneous MCT and have not been validated for non-cutaneous MCT (Elliott et al., 2016; 
Thompson et al., 2011). In subcutaneous tumors it has been shown that grade is not indicative of 
behavior. However other factors such as an infiltrative growth pattern have been associated with 
MCT mortality with mortality being approximately 3x more likely with an infiltrative growth 
than in well circumscribed tumors (Thompson et al., 2011). Mitotic index has also been 
associated with prognosis in subcutaneous MCT with a MI >4 having a median survival time of 
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140 days and being 54x more likely to have metastatic disease than a dog with a MI of 0 
(Thompson et al., 2011).  
Other types of non-cutaneous MCT in canines include mucosal MCT and conjunctival 
MCT (Elliott et al., 2016; Fife, Blocker, Fife, Dubielzig, & Dunn, 2011). Similar to subcutaneous 
tumors, conjunctival tumors have a low risk of local recurrence, are unlikely to have metastatic 
disease and overall have a good prognosis (Fife et al., 2011). In contrast to subcutaneous MCT, 
mucosal MCT are associated with a worse prognosis. A recent study evaluating mucosal MCT 
found that there was a 55% lymph node metastatic rate at the time of diagnosis and that both MI 
(MI >3 and MI >5 were prognostic cutoff points) and lymph node metastasis had a poor 
prognosis (Elliott et al., 2016). Dogs with lymph node metastasis had an overall survival time of 
276 days and dogs without adequate local control had a median overall survival time of 150 days 
(Elliott et al., 2016).  Where adequate local control was defined as a complete excision on 
histopathology or a microscopically (not grossly) incomplete excision followed by radiation 
therapy.  
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CHAPTER 3: 
EVALUTION OF THE EFFECTS OF ANATOMIC LOCATION, HISTOLOGIC 
PROCESSING AND MARGIN SIZE ON THE DEGREE OF SHRINKAGE OF SKIN 
SAMPLES AFTER SURGICAL EXCISION 
 
3.1 INTRODUCTION 
Safety margins are considered to be the required distance from a given tumor that will 
theoretically result in complete excision of the tumor; safety margins are used in surgical 
planning (Kope et al., 2005). These margins usually are derived from studies conducted to 
evaluate outcome related to histologic margins or outcome compared to the macroscopic safety 
margins used during surgery. The concept of a safety margin has many confounding factors; 
however, understanding the relationship of these planned surgical margins to histologically 
determined margins is necessary to better interpret outcomes related to these measures (Becker, 
2007; Kope et al., 2005; Reimer et al., 2005). 
Histopathologic margins are often the standard used to measure success of surgical 
resection and have been associated with the prognosis for a patient (Kamstock et al., 2011; 
Reimer et al., 2005). The working definition of a histopathologic margin is the distance from the 
cut edge of the surgical sample to the closest identifiable tumor cell (Auw-Haedrich, Frick, 
Boehringer, & Mittelviefhaus, 2009; Donnelly et al., 2015). Although histopathologic margins 
are often considered a defined and objective measure, there are many sources of error and 
subjectivity that can add uncertainty to interpretation of the results. For cutaneous tumors, 
separation of deeper anatomic layers from the skin, type of tumor, surgical method, postoperative 
handling, method of histologic sectioning, and various patient factors can all influence 
measurements of histopathologic margins (Becker, 2007; Donnelly et al., 2015; Giudice et al., 
2010; Hudson-Peacock et al., 1995; Kope et al., 2005). Also, the phenomenon of shrinkage (i.e., 
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change in sample size between presurgical measurements and post-histologic processing) has 
been described (Dauendorffer et al., 2009; Gregory et al., 2003; Hudson-Peacock et al., 1995; 
Kerns et al., 2008), and this phenomenon further complicates interpretation of histopathologic 
margins in relation to planned surgical margins.  
Most of the studies conducted to evaluate skin shrinkage after surgical excision have 
been performed on samples obtained from humans. Factors reported to influence the amount of 
skin shrinkage include patient age, location of the tumor, inherent elasticity of the skin in that 
patient, and presence of scar tissue (Kerns et al., 2008). However, there have been conflicting 
results that indicate age, sex, and skin lesion type (benign vs. malignant) do not affect shrinkage 
(Dauendorffer et al., 2009). It was once commonly believed that histologic processing, 
specifically formalin fixation, may affect skin shrinkage. However, studies in human 
(Dauendorffer et al., 2009; Kerns et al., 2008) and veterinary (Upchurch et al., 2014) medicine 
have found that formalin fixation has little or no effect on change in sample size.  
Shrinkage of samples of clinically normal skin of dogs has been evaluated in 2 studies 
(Reimer et al., 2005; Upchurch et al., 2014). Investigators in the earlier study (Reimer et al., 
2005) found that the degree of shrinkage is dependent on location and reported that inclusion of a 
muscle layer but not a fascial plane may decrease the amount of shrinkage. Investigators in the 
latter study (Upchurch et al., 2014) evaluated sample size, location, and tension lines; however, 
in contrast to the earlier study, they did not find that location affected skin shrinkage. Although 
the earlier study did include histologic processing, effects of processing were not assessed 
independently from effects of formalin fixation. The effect of histologic processing on size of 
skin samples was not assessed in either study.  
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The purpose of the study reported here was to examine the relationship between planned 
surgical and histopathologic margins by evaluating factors (e.g., size of skin sample, anatomic 
location, and histologic processing) that may affect shrinkage. We hypothesized that the degree 
of shrinkage of histologically processed clinically normal skin samples differs on the basis of 
sample size and location and that shrinkage occurs following histologic processing but to a lesser 
degree than the shrinkage that occurs between excision and formalin fixation.  
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3.2 MATERIALS AND METHODS 
3.2.1 Sample 
Skin samples were obtained from 15 canine cadavers consisting of 13 pit bull–type 
terriers and 2 mixed-breed dogs (6 sexually intact males, 6 sexually intact females, and 3 
neutered males). Dogs of breeds with thin skin (e.g., greyhounds) or excessively loose skin were 
excluded. Cadavers were restricted to dogs with a body weight between 15 and 35 kg and with a 
body condition score of 4 to 6 on a scale of 1 to 9 (Laflamme, 1997). The skin was required to 
have a grossly normal appearance with no evidence of neoplasia, scars, current lesions, or 
previous dermatologic disease. The cadavers were obtained from a local animal shelter, and 
samples were collected within 2 to 8 hours after dogs were euthanized. All dogs used in this 
study were euthanized for reasons unrelated to the study.  
 
3.2.2 Sample Collection and Processing 
Templates were created to serve as a guide for excision of skin samples. Templates 
consisted of durable water-resistant foam and represented 10-mm and 30-mm margins from a 
central marker. For the 10-mm samples, length and width of the ellipse was 40 mm and 20 mm, 
respectively. For the 30-mm samples, the length and width of the ellipse was 120 mm and 60 
mm, respectively. These dimensions were chosen because they replicated lateral margins created 
from a central point (e.g., tumor), with the length being 2 times the width. Because the tumor in 
this study was a pinpoint, the sample size was considered equal to half the diameter of the width. 
This elliptical shape is commonly used clinically to increase the ease of skin closure.  
A 10-mm sample and a 30-mm sample were collected from each of 3 anatomic locations 
(head, hind limb, and lumbar region) on each cadaver (Figure 1). Sample size (10 mm or 30 
	   34	  
mm) was randomly allocated via coin toss to a side for each cadaver; all 10-mm samples were 
collected from one side of a cadaver, and all 30-mm samples were collected from the other side 
of that cadaver. Cadavers were placed in lateral recumbency for collection of skin samples from 
the hind limbs and lumbar region and in sternal recumbency for collection of skin samples from 
the head. Hair was clipped from each location prior to collection of samples.  
Samples from the head were centered over the temporal region, with the long axis of the 
ellipse placed in a cranial-to-caudal direction. For samples from the lumbar region, the center 
was placed at the midpoint between the last rib and the crest of the wing of the ilium at a point 
approximately 4 to 5 cm lateral to the vertebral spinous processes; the long axis of the ellipse 
was placed in a cranial-to-caudal direction. For skin samples collected from the hind limbs, the 
patella and greater trochanter were detected by use of manual palpation, and the sample was 
centered between these 2 points. Samples were obtained cranial to the long axis of the femur, and 
the long axis of the ellipse was placed parallel to the line of tension (Irwin, 1966). Direction of 
the ellipse was chosen on the basis of a consistent fascial layer with minimal muscle attachment, 
to facilitate bilateral positioning for collection of the samples, or both.  
The template was lightly held in place so that the skin was pulled or stretched as little as 
possible. By use of the template, an ellipse was drawn on the skin with a fine-point marker, and a 
needle coated in surgical ink (Davidson marking system, Bradley Products Inc, Bloomington, 
Minn.) was used to mark the center (Figure 2). The template was removed, and the margins 
were measured for accuracy by use of a soft ruler accurate to 1 mm.  
A partial-thickness skin incision through the epidermis was made along the marked 
ellipse (Figure 2). A photograph of the ellipse and ruler was obtained. Photographs were 
subsequently used to calculate SA. Length (long axis of the ellipse) and width (widest point of 
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the ellipse perpendicular to the long axis) were measured prior to excision of the samples (i.e., 
first processing stage; P1). Initially, 3 measurements were obtained and the mean value 
calculated for use; however, this practice was discontinued because of the highly repeatable 
nature of length and width measurements. After the length and width were measured, the incision 
was extended deeper into the skin at the points used to measure the length and width until the 
fascial layer could be identified. A depth gauge typically used for cortical bone measurements 
was used to measure the P1 depth (distance from the surface of the skin to the fascial layer). The 
most cranial, caudal, lateral (or medial) and dorsal (or ventral) extents of the incision were 
marked with different colors of surgical ink (Davidson marking system, Bradley Products Inc., 
Bloomington, Minn.); the ink was allowed to air dry for 10 minutes. A full- thickness skin 
incision was made on half of the sample, and the remainder of the deep fascial layer was 
undermined. The skin was loosely sutured to the fascia at 3 of the ink-marked points to prevent 
movement of fascia prior to completion of the skin incision and sample removal. Once the 
sample was excised, a fourth suture was placed at the remaining ink-marked point. Samples were 
placed flat on the bottom of a sample container and immersed in neutral-buffered 10% formalin 
(approx. 1 part tissue to 10 parts formalin) for 24 to 48 hours. Measurements as described for P1 
were again obtained at 24 to 48 hours after the start of formalin fixation (i.e., P2). The same 
investigator (JKR) performed all measurements at P1 and P2. After the length and width 
measurements were obtained at P2, photographs were obtained and subsequently used to 
calculate SA.  
Samples were trimmed via radial cuts. The first cut was made on the short axis between 
the ink-marked points. Samples were then cut on the long axis between the ink-marked points. 
The trimmed samples were subjected to standard embedding in paraffin. Slides were stained with 
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H&E stain and evaluated by a board-certified veterinary pathologist (KS). Measurements of the 
long and short axis for each of the trimmed sections for each slide were added to determine the 
length and width, respectively, at this processing stage (i.e., P3). Because of tissue sectioning and 
creation of artifacts during histologic processing, depth was not measured at P3.  
Photographs obtained at P1 and P2 were used to calculate SA. Publically available 
software (Rasband WS. ImageJ, version 1.48, 1997–2014. Bethesda, Md: US National Institutes 
of Health. Available at: http://imagej.nih.gov/ij/. Accessed April, 30th, 2014.) was used for SA 
calculations.  
 
3.2.3 Statistical Analysis 
Descriptive statistics were calculated for body condition score and body weight. 
Continuous variables were assessed for normality by analyzing histograms for skewness and 
kurtosis and by use of the Shapiro-Wilk test. Mean and SD were reported for normally 
distributed variables, and median and range were reported for nonnormally distributed variables. 
Percentage change for length, width, depth, and SA between P1 and P2 was calculated by use of 
the following equation: ([P1 measurement – P2 measurement]/P1 measurement) X 100. 
Percentage change for length and width between P2 and P3 was calculated by use of the 
following equation: ([P2 measurement – P3 measurement]/P2 measurement) X 100. Percentage 
change for length and width between P1 and P3 was calculated by use of the following equation: 
([P1 measurement – P3 measurement]/P1 measurement) X 100. All calculations were performed 
with commercially available software (Microsoft Excel for Mac 2011, version 14.4.4, Microsoft 
Corp, Redmond, Wash.). Linear mixed models of commercially available statistical software 
(SAS software, version 9.3 of the SAS system for PC, SAS Institute Inc, Cary, NC.) were used to 
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evaluate the effect of time, anatomic location, and sample size on changes in measurements of 
length, width, and SA. Length, width and SA represented fixed effects, and dog was a random 
effect. This statistical method was used because of the loss of 1 data point for SA. Significance 
was set at values of P < 0.05. 
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3.3 RESULTS 
3.3.1 Samples 
A total of 90 samples were obtained from the 15 cadavers (6 samples/cadaver). Median 
body condition score was 5 (range, 4 to 6), and mean ± SD body weight was 23.6 ± 3.9 kg. All 
measurement data were available for all samples, except for 1 missing data point for the SA 
calculation of 1 dog because of a lost photograph.  
 
3.3.2 Change in Absolute Length and Width of Samples 
Time, anatomic location, and sample size all influenced length, width, and SA. Mean and 
SD of the length and width for each anatomic location and sample size were summarized 
(Tables 1 and 2).  
Absolute length and width decreased significantly (P < 0.001) from P1 through P3 for 
both sample sizes and all anatomic locations. There were significant (P < 0.001) decreases in 
length and width between P1 and P2, P2 and P3, and P1 and P3. Generally the decrease in length 
and width between P2 and P3 was less than that between P1 and P2 for the 3 anatomic locations; 
these changes were more marked in the 30-mm samples.  
Length and width of all samples at the 3 anatomic locations decreased significantly (P < 
0.001) over time (P1 through P3) for both sample sizes. Hind limb samples had a significantly (P 
< 0.001) greater decrease in length, compared with results for samples obtained from the lumbar 
region and head, between P1 and P2, P2 and P3, and P1 and P3 for both sample sizes. Samples 
from the lumbar region had an intermediate decrease, and samples from the head had the 
smallest decrease in length; results for each of these anatomic locations differed significantly (P 
< 0.001) from results for all other locations for all processing stages and both sample sizes. The 
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absolute change in width was similar for both sample sizes for all locations among all 3 
processing stages.  
Sample length decreased significantly (P < 0.001) for both 10-mm and 30-mm samples 
between PI and P2, P2 and P3, and P1 and P3 for all anatomic locations. Decrease in length was 
significantly (P < 0.001) greater for 30-mm samples than for 10-mm samples for all anatomic 
locations and processing stages. The decrease in sample width between P2 and P3 was less that 
between P1 and P2 for all anatomic locations and both sample sizes.  
 
3.3.3 SA 
Mean and SD of the SA for each anatomic location and sample size were summarized 
(Table 3). The SA decreased by 10.3% to 59.3% between P1 and P2 for all samples. Mean ± SD 
percentage change for the SA for the 10-mm samples from the head, lumbar region, and hind 
limb was 33.5 ± 12.6%, 37.5 ± 9.8%, and 40.0 ± 10%, respectively. Mean percentage change for 
the SA for the 30-mm samples from the head, lumbar region, and hind limb was 34.1 ± 9.9%, 
39.4 ± 0.1%, and 48.8 ± 6.3%, respectively.  
 
3.3.4 Percentage Change in Length and Width 
Percentage change in length and width between P1 and P2, P2 and P3, and P1 and P3 was 
evaluated for each sample size and anatomic location (Tables 4 and 5). Percentages were 
calculated because they were believed to be a more clinically relevant and intuitive measure than 
was the absolute change.  
For all locations and sample sizes, the percentage change between P1 and P3 ranged from 
24.0% to 37.7% for length and from 18.0% to 22.8% for width (Tables 4 and 5). Mean 
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percentage change in width between P2 and P3 was less than the mean percentage change in 
width between P1 and P2. In general, the mean percentage change in length was greater than the 
mean percent change in width between P2 and P3, relative to their corresponding changes 
between P1 and P2. Mean percentage change in length or width of all samples was greater 
between P1 and P3, compared with the percentage change between P1 and P2.  
Hind limb samples had a greater difference in the mean percentage change in length 
between P1 and P2, compared with results for lumbar region samples, which was greater than 
results for head samples (Tables 4 and 5). Mean percentage change in width between P1 and P2 
was similar for all anatomic locations and sample sizes, except for the 10-mm hind limb sample. 
Mean percentage change in length between P1 and P3 was greater for hind limb samples than for 
the other locations.  
Mean percentage change for 10-mm samples between P2 and P3 generally was greater 
than that for the corresponding 30-mm samples (Tables 4 and 5). Mean percentage change for 
the 30-mm samples between P1 and P2 generally was greater than that the 10-mm samples. 
Mean percentage change in length and width between P1 and P3 was similar for both sample 
sizes, although there was greater variation in length for the 30-mm samples. 
 
3.3.5 Percentage Change in Depth 
Mean ± SD percentage change in depth between P1 and P2 ranged from –30.9 ± 22.7% to 
6.0 ± 13.6%. In general, depth increased between P1 and P2. 
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3.4 DISCUSSION 
Tumor type and histopathologic margins are two of the most important factors considered 
when making treatment recommendations for cutaneous tumors. Although the diagnosis of tumor 
type may be straightforward, interpretation of histopathologic margins has many complicating 
factors. Efforts have been made in human medicine to further define the relationship between 
histopathologic and surgical margins for various tumor types and tissues, including tongue or 
labiobuccal tissue (Johnson et al., 1997), rectal cancer (Eid et al., 2007), and nonmelanoma skin 
cancer (Lane & Kent, 2005). However, this relationship is poorly understood in veterinary 
medicine, with only a handful of studies (Fulcher et al., 2006; Reimer et al., 2005; Risselada et 
al., 2015; Simpson et al., 2004; Upchurch et al., 2014) conducted to correlate planned surgical 
margins to histopathologic margins. Before attempting to define this relationship for various 
tumor types in clinical settings, it is important to gain a better understanding of the manner in 
which surgical handling, histologic processing, and patient factors affect shrinkage in 
anatomically normal canine skin.  
In the study reported here, decreases in absolute length and width following excision and 
histologic assessment (P1 to P3) and shrinkage in relation to sample size and anatomic location 
corroborated results of other veterinary studies conducted to evaluate shrinkage. The overall 
percentage shrinkage from the time of excision planning through histologic processing ranged 
from 24.0% to 37.7% for length and 18.0% to 22.8 % for width. This is similar to previously 
reported findings of a total surface change of 21.2% to 32% for canine skin samples (Reimer et 
al., 2005) and 21% for human skin samples (Gregory et al., 2003). Sample shrinkage is an 
important consideration when attempting to plan surgical margins based on histopathologic 
margins. Although these results cannot be directly translated to clinical cases, if these findings 
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were similar for a given tumor type, a 10-mm histologic margin may equate to approximately a 
13- to 16-mm planned surgical margin (safety margin).  
Recommendations for size of planned surgical margins differ greatly depending on tumor 
type. Marginal resections are recommended for some benign cutaneous tumors, whereas at the 
other extreme, planned surgical margins of up to 5 cm are recommended for vaccine-associated 
feline sarcomas (Phelps, Kuntz, Milner, Powers, & Bacon, 2011). Except for a recent study, 
(Upchurch et al., 2014) investigators in other studies have not evaluated whether size of the 
sample has an effect on shrinkage. In the present study, we found that histologic processing, 
anatomic location, and sample size all had an effect on the amount of change in length, width, 
and SA between the processing stages. To our knowledge, this was the first study of canine 
samples that revealed sample size affected the amount of skin shrinkage. In comparing the 
commonly planned margins of 10 and 30 mm, length had a greater absolute decrease for 30-mm 
samples than for 10-mm samples at all anatomic locations and processing stages. When the 
percentage change was evaluated, percentage change in length between P1 and P2 for the 30-mm 
samples was greater than the change for the equivalent 10-mm sample (13.7% vs 15.1%, 23.8% 
vs. 30.6%, and 17.2% vs. 19.7% for head, hind limb, and lumbar region, respectively). However, 
when the percentage change between P1 and P3 was evaluated, percentage changes were 
relatively similar when comparing 10-mm and 30-mm samples for the same anatomic location.  
Each anatomic location had differing degrees of skin shrinkage. The hind limb sample 
had the greatest decrease in length and width for all processing stages for both sample sizes, 
whereas the lumbar region samples had an intermediate decrease, and the head samples had the 
smallest decrease. Investigators in another study (Reimer et al., 2005) also found that samples 
obtained from a hind limb distal to the stifle joint (as opposed to proximal to the stifle joint in the 
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present study) had an increase in shrinkage, compared with shrinkage for sites on the head and 
thorax, providing further support that the hind limb may be predisposed to more shrinkage than 
other regions of the body. This behavior may be related to the inherent increase in elasticity or 
mobility of the skin in that hind limb region necessary for movement. However, results for the 
study reported here are in contrast to those of a recent study (Upchurch et al., 2014) in which 
investigators found differences in margins and location had no effect on shrinkage. In that study, 
(Upchurch et al., 2014) investigators specifically aimed to evaluate shrinkage related to tension 
lines; however, the study design differed from that of the present study because they collected 
circular samples (2, 4, and 6 cm). Possible reasons proposed for the differences in findings 
related to location include differences in sample excision technique, sample shape, breed, and 
live animals versus cadavers. Given that similar animals were used in both the aforementioned 
study (Upchurch et al., 2014) and the present study, shape, location, and excision technique were 
the most probable contributors. Skin in the pelvic limb, particularly in the cranial portion of the 
thigh, is highly mobile, and even mild tension can change the amount of skin removed. Also, 
evaluation in the other study included only up to the point at 24 hours of formalin fixation 
(equivalent to P2 in the present study) and did not include histologic evaluation. Because the 
present study found that histologic processing contributed substantially to the final amount of 
shrinkage, the lack of histologic evaluation in the previous study (Upchurch et al., 2014) may 
also have accounted for the differences in results related to the use of various sample sizes. In the 
aforementioned study, (Upchurch et al., 2014) results of total percentage shrinkage (equivalent to 
between P1 and P2 for the present study) ranged from 10.25% to 18.25% and were similar to our 
results for the same processing stage when hind limb samples were excluded (13.7% to 19.7%).  
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In general, the mean percentage changes in length between P1 and P2 were greater for the 
30-mm samples at a given location than for the 10-mm samples; however, this pattern was 
diminished when comparing changes between P1 and P3 for the 30-mm and 10-mm samples. 
Because the 10-mm samples proportionally had a greater mean percentage change between P2 
and P3, in comparison to the percentage change for the 30-mm samples, this variation was likely 
attributable to effects of histologic processing. Histologic processing had a major effect on 
shrinkage. The mean ± SD percentage change between P2 and P3 ranged from 5.1 ± 7.3% to 
19.5 ± 5.8% for the 10-mm samples and 4.2 ± 8.8% to 11.9 ± 3.7% for the 30-mm samples. 
Cutting of samples for histologic examination results in the loss of 1 to 2 mm of tissue. It follows 
that this loss would have a greater effect on a small sample than on a large sample. Another 
possible factor that may have contributed to the difference between the results was interobserver 
measurement error.  
Histologic processing consists of many steps, including fixation in formalin, embedding 
in paraffin, trimming of tissue, tissue staining, and microscopic evaluation of the tissue 
(Kamstock et al., 2011). Skin shrinkage during formalin fixation has been evaluated in both 
human and veterinary medicine, and most reports (Dauendorffer et al., 2009; Kerns et al., 2008; 
Reimer et al., 2005; Upchurch et al., 2014) indicate that shrinkage as a result of histologic 
processing is minimal. Because this change reportedly is minimal, it was not directly evaluated 
in the present study, but it may have contributed to some of the differences between P1 and P3. 
In addition to the tissue that is lost during cutting, there may be some changes to the 
conformation of the tissue during histologic preparation of the tissue prior to cutting. These 
losses are difficult to quantify and will likely differ according to each sample being processed.  
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As part of the methods use in the present study, locations that were measured were 
marked with surgical ink in an attempt to decrease the error associated with obtaining 
measurements at different locations. It was evident during examination of samples after formalin 
fixation that considerable conformational changes occurred in the samples that made it 
challenging to obtain accurate measurements despite precise marking of the locations to be 
measured. Some of these changes included rolling of the sample edges; movement, separation, 
and rotation between the subcutaneous, fascial, and dermal layers; and general distortion of the 
sample as a result of contraction. Specific protocols were implemented in the present study to 
attempt to limit these changes associated with tissue handling and formalin fixation. Only half of 
each sample was dissected at a time to ensure the layers remained appropriately aligned. A loose, 
simple-interrupted suture was placed at the measurement locations before removal of a sample 
from a cadaver to limit shifting of dermal layers. Samples were placed flat on the bottom of 
formalin containers, and formalin was gently added to ensure the samples remained as flat as 
possible. Anecdotally, we found that these practices greatly increased the ability to more 
consistently measure differences between processing stages. Without use of these practices, it 
would have been difficult or impossible to obtain consistent measurements. Difficulties 
encountered in this study and the benefits of specific practices in sample acquisition and 
preparation highlight the importance of meticulous sample preparation in clinical cases to ensure 
that accurate margin interpretation by a veterinary pathologist is possible. Practices regarding 
perioperative and postoperative handling of tissue samples can impact the interpretation of 
margins, and further studies to evaluate these practices are warranted. Currently, these practices 
are not standardized. For example, in some studies (Fulcher et al., 2006; Simpson et al., 2004) 
conducted to evaluate mast cell tumors of dogs, the specimens were pinned to cardboard in their 
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approximate original shape prior to formalin fixation. The manner in which changes in post-
excisional handling of tissues (e.g., pinning) affect shrinkage and margin interpretation is 
unknown.  
In an attempt to further quantify overall shrinkage, SA was compared between P1 and P2. 
The SA decreased between 10.3% and 59.3 % for all samples between P1 and P2; however, the 
mean ± SD percentage change between samples ranged from 34.1 ± 9.9% to 48.8 ± 6.3%. The 
major source of this variability likely was related to the method of SA evaluation. The SA was 
calculated from 2-D images; however, the samples curved with the lines of the cadaver and were 
not in a flat plane in P1 SA images. Images were centered over the samples to account for this as 
much as possible in P1 images; however, distortion caused by normal body curvature, compared 
to flat skin, likely caused considerable variability in SA calculations.  
In general, samples appeared to increase in thickness (i.e., depth) between P1 and P2 for 
the 4 measurement points. However, there was a wide range in the mean ± SD percentage change 
among the measurement points (range, –30.9 ± 22.7% to 6.0 ± 13.6%). Most of the means were 
negative, and a negative number represented an increase in thickness. To the authors’ 
knowledge, this was the first study in veterinary medicine in which investigators attempted to 
measure depth at P1. A previous study (Reimer et al., 2005) revealed an increase in thickness 
between stages equivalent to P2 and P3. Because of the distortion (i.e., movement or separation 
between the fascial layers) that occurs during histologic processing, depth was not measured at 
P3 in the study reported here because it was thought likely to be inaccurate.  
Limitations of the present study were related to the nature of basic research and use of 
cadavers. It was possible that postmortem changes within canine skin could have affected the 
innate properties of skin and therefore skin shrinkage. Skin samples in this study were obtained 
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within 2 to 8 hours after dogs were euthanized to mitigate postmortem effects. Results of this 
study were consistent with those of another study (Reimer et al., 2005) that involved the use of 
live dogs, which suggested that the use of cadaveric tissue had a small or no effect on outcomes. 
Also, use of cadavers allowed collection of a greater number of samples, which decreased 
inherent statistical error. Another limitation of this study was that it was performed with 
anatomically normal canine skin and did not account for effects that a tumor may have on skin 
shrinkage. A recent retrospective study (Risselada et al., 2015) conducted to evaluate histologic 
shrinkage specifically for mast cell tumors found that the mean shrinkage was 35% to 42% and 
that there was a greater percentage shrinkage in appendicular than in truncal samples in certain 
directions. These percentages are similar to but overall greater than those for the present study. 
This difference may have been a reflection of the effect of the tumor, use of live vs. cadaveric 
tissue, size of the tissue excised or limitations inherent within a retrospective study design such 
as variations in record keeping, individual measurement techniques, and tumor morphology.  
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3.5 CONCLUSIONS 
On the basis of the results for the present study, the primary hypotheses were accepted 
that anatomic location and sample size affected the degree of shrinkage when comparing surgical 
margins to histopathologic margins. Also, the secondary hypothesis that shrinkage following 
histologic processing (P2 to P3) was less than between excision and formalin fixation (P1 to P2) 
was also accepted. Given that investigators of previous studies (Dauendorffer et al., 2009; Kerns 
et al., 2008; Upchurch et al., 2014) have found that formalin fixation has minimal effects on 
shrinkage, this suggests that most of the skin shrinkage likely occurred directly after excision. 
The next step in this line of research would be to further define factors that affect margin 
evaluation, such as evaluating shrinkage in relation to margins for various cutaneous tumor types 
to determine the role of the tumor in shrinkage. Other factors to be evaluated that may affect 
shrinkage include other potential tumor locations and various methods of periexcisional and 
post-excisional handling of samples. The information presented within this chapter has been 
previously published (Reagan et al., 2016).  
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CHAPTER 4:  
EVALUATION OF INFORMATION PRESENT WITHIN MAST CELL TUMOR 
HISTOPATHOLOGY REPORTS: 2012-2015 
 
4.1 INTRODUCTION 
The histopathology report is the primary form of communication between the clinician 
and pathologist (Kamstock et al., 2011; Newman, 2003). The pathologist’s ability to provide 
useful information to the clinician is dependent on the quality of the clinician’s input such as 
providing an accurate history with detailed physical exam findings as well as performing 
appropriate sample submission and margin marking (Brannick, Zhang, Zhang, & Stromberg, 
2012; Kamstock et al., 2011). Likewise, the pathologist is expected to provide a diagnosis when 
possible and any histologic parameters that may predict biologic behavior (e.g. recurrence or 
metastasis) for that specific tumor type such as reporting of margins (Kamstock et al., 2011; 
Newman, 2003). 
Kamstock et al. published a consensus providing guidelines and recommendations on 
veterinary surgical pathology reporting (Kamstock et al., 2011). Generally they recommended 
that a report should include the following components: diagnosis, grade when applicable, 
microscopic description, comments/remarks and references (Kamstock et al., 2011). Related to 
grade, it was recommended that grade be listed after the diagnosis, the features used to arrive at 
that grade should be described, and a reference should be reported for the grading scheme 
(Kamstock et al., 2011). Other specific features of the report that were discussed included mitotic 
index (MI) and histologic margins. They stated that MI should be listed as the number of mitotic 
figures per number of high power field (ideally minimum of 10 high power fields) (Kamstock et 
al., 2011). When reporting margins, the method of trimming should be reported. Also, margin 
evaluation should include a description of the closest neoplastic cells, an objective measure from 
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the closest neoplastic cell to the margin, and the tissue types/quality composing the margin 
(Kamstock et al., 2011).  
Recently the VCS Oncology-Pathology Working Group MCT Subgroup published a 
consensus on cutaneous mast cell tumor (MCT)("VCS Oncology-Pathology Working Group 
MCT Subgroup Consensus on Grading Canine Cutaneous MCT," 2013) grading which 
recommended that both Kiupel (Kiupel et al., 2011) and Patnaik (Patnaik et al., 1984) grading 
systems be reported and that MI should be standardized in a similar fashion as that recommended 
by Kamstock et al. ("VCS Oncology-Pathology Working Group MCT Subgroup Consensus on 
Grading Canine Cutaneous MCT," 2013). It was also stated that grade should be used in 
conjunction with the overall clinical picture and other prognostic indicators to predict biologic 
behavior and recommend treatment options ("VCS Oncology-Pathology Working Group MCT 
Subgroup Consensus on Grading Canine Cutaneous MCT," 2013). For MCT, many prognostic 
factors have been evaluated that may be present in the histopathology report. Prognostic 
information that may be included within the history section includes presence of clinical signs 
(Mullins et al., 2006), tumor location (Garrett, 2014; Gieger et al., 2003; Kiupel et al., 2005), 
number of concurrent tumors (Kiupel et al., 2005), stage (Garrett, 2014) and tumor size (Mullins 
et al., 2006). While information supplied by the pathologist associated with MCT prognosis 
includes MI (Berlato et al., 2015; Elston et al., 2009; Garrett, 2014; Romansik et al., 2007; van 
Lelyveld et al., 2015), histologic grade (Donnelly et al., 2015; Garrett, 2014; Kiupel et al., 2011; 
Murphy et al., 2004; Patnaik et al., 1984; Sabattini et al., 2015; Stefanello et al., 2015; Takeuchi 
et al., 2013), histologic margins (Donnelly et al., 2015; Garrett, 2014; Mullins et al., 2006; 
Scarpa et al., 2012; Schultheiss et al., 2011; Seguin et al., 2006; Weisse et al., 2002) and various 
cellular markers (Berlato et al., 2015; Costa Casagrande et al., 2015; Garrett, 2014; Kandefer-
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Gola et al., 2015; Maglennon et al., 2008; Scase et al., 2006; Seguin et al., 2006; Takeuchi et al., 
2013; van Lelyveld et al., 2015; Vascellari et al., 2013; Webster et al., 2007).  
Histopathology reports are critically important in the clinician’s decision-making process 
regarding necessity and mode of adjunctive therapy recommended after tumor removal 
(Kamstock et al., 2011; Newman, 2003). However, anecdotally considerable variation exists in 
the types of information in histopathological reports for MCT especially relating to histologic 
margins and the grading system used. The purpose of this study was to describe and evaluate the 
information present within histopathology reports for surgically resected canine cutaneous MCT. 
We hypothesized that both Kiupel and Patnaik grading systems would be used for cutaneous 
MCT but not all reports would contain both grades. Also, margin reporting would be variable 
and not all reports would contain complete information on lateral and deep surgical margins.  
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4.2 MATERIALS AND METHODS 
Histopathology reports for cases diagnosed as MCT from January 1st 2012 to May 31st 
2015 were collected from various clinicians across the United States. The United States were 
divided into 4 regions (table 6) based on the regions described in by the United States Census 
Bureau (website).  
All clinicians contributing histopathology reports were board certified specialists 
(medical oncologist or surgeon), however the reports submitted could have been requested by a 
referring veterinarian or the contributing veterinarian or their colleagues. The institutions 
associated with the contributing clinicians were comprised of veterinary teaching hospitals and 
private specialty practices. It was requested that reports from their most recent MCT cases that 
were eligible were submitted for evaluation. A maximum of 15 reports were collected from each 
contributor.  
All clinicians participating in the study were asked to complete a basic questionnaire 
related to their associated institution and to submit a copy of each final histopathology report. 
The questionnaire gained information related to the practice including: type of practice (specialty 
referral practice or veterinary teaching hospital), the practice’s name, contact information and the 
name/credentials of the clinician collating the reports. Inclusion criteria for the study required the 
following: submission of a completed questionnaire and final canine histopathology report with 
diagnosis of MCT, a microscopic description must be included in the histopathology report, and 
this must have been the first attempt at MCT excision. Incisional biopsies were excluded. The 
reports were evaluated based on recommended general histopathologic reporting guidelines 
(Kamstock et al., 2011)and types of data evaluated are listed in table 7. The reports were 
evaluated by 2 individuals (JKR and CF). Interobserver error was not assessed, however, JKR 
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reviewed all columns that contained subjective interpretation (see table 2) and any disagreement 
was adjudicated by LES.  
Descriptive statistics were calculated for each category. Continuous variables were 
assessed for normality by analyzing histograms for skewness and kurtosis, and by Shapiro-Wilk 
test. If variables were normally distributed mean and standard deviation was presented or if they 
were not normally distributed the median and range were presented. All statistics were 
performed using commercially available software (Microsoft Excel for Mac 2011, version 14.4.4, 
Microsoft Corp, Redmond, Wash. and SAS software, version 9.3 of the SAS system for PC, SAS 
Institute Inc, Cary, NC.). 	  
.  
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4.3 RESULTS 
A total of 395 MCT histopathology reports were received from 26 contributors across the 
United States. Twenty-seven reports did not meet the inclusion criteria and were excluded from 
statistical analysis. Of the remaining 368 reports, 96 (26.1%) were from the Midwest, 82 (22.3%) 
were from the Northeast, 99 (26.9%) were from the South and 91 (24.7%) were from the West. 
Across all regions, laboratories associated with veterinary universities produced 121 of the 
reports (32.9%), private laboratories created 227 of the reports (61.7%) and in 20 reports (5.4%) 
the laboratory could not be determined.  
 
4.3.1 Signalment and Clinical History:  
Information on the patient signalment was present in 316 (85.9%) of the reports with 65 
breeds represented. The highest frequencies of reports were from the following breeds: Labrador 
retriever (13.1%, 48 reports), mixed breed (12.3%, 45 reports), boxer (7.1%, 26 reports) and 
golden retriever (6.5%, 24 reports). For sex, 38.3% (141 reports) were male, 46.2% (170 reports) 
were female and 15.5% (57 reports) were missing this data. A clinical history or description of 
the lesion was given in 315 reports (86%). The median number of words in the history was 17 
(range 0-317). The description of the clinical history was considered adequate in 175 reports 
(47.6%) (see Table 7 for the definition of adequate). The most common historical information 
provided was the location of the lesion (292 reports, 79.3%), suspected tumor type (219 reports, 
59.5%) and method of diagnosis of the suspected tumor type (122 reports, 33.2%). Other 
information provided included duration of disease (96 reports, 26.1%), number of masses present 
(81, 22%), size (70 reports, 19.0%), growth rate (48 reports, 13.0%), age at diagnosis (41 reports, 
11.1%) and medications the patient has received (31, 8.4%).  
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4.3.2 Gross and Microscopic Description:  
A gross description was reported in 97 reports (26.4%) with 1 report containing images 
of the sample. Of the reports that contained a gross description, 43 reports measured the sample 
size in three dimensions, 23 in two dimensions and 21 reports in one dimension. Mitotic index 
was given in 126 reports (34.2%) and mitotic figures per high power per field were listed in 342 
reports (92.9%). Seven reports (1.9%) did not list a MI or mitotic figures per high power field. 
The tissue of origin was recorded as cutaneous in 280 reports (76.1%), subcutaneous in 52 
reports (14.1%), muscular in 4 reports (1.1%), unknown in 4 reports (1.1%), 
submucosal/mucosal in 2 reports (0.5%) and the description of the tissue of origin was missing in 
26 reports (7.1%). 
 
4.3.3 Histologic Margins:  
Some description of histologic margins was present in 356 reports (96.7%), however 
description of both lateral and deep margins was present in only 284 reports (77.2%). The 
histologic margins were quantified in centimeters or millimeters in 287 reports (78.0%). 
Subjective descriptors (e.g. clean, close, etc.) were used in 88 reports (23.9%) while 188 reports 
(51.1%) specifically stated complete vs. incomplete margins. The direction (e.g. cranial, caudal, 
etc.) of the closest lateral margin was noted in 60 reports (16.3%). The tissue type composing the 
margin, the quality of the tissue composing the margin and a description of the neoplastic cells 
closest to the margin were rarely recorded (40 reports/10.9%, 4 reports/1.1% and 2 reports/0.5% 
respectively). The method of sample trimming was noted in 62 reports (16.8%), and 123 (33.4%) 
of the reports had an indication that the margins were marked with ink or suture. Only 16 reports 
(4.3%) contained the surgeon’s planned margin at the time of surgery. 
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4.3.4 Grading System:  
For cutaneous tumors, a grade was given in 308 reports (98.7%). For non-cutaneous 
tumors, a grade was stated on 39 reports (67.2%), while 26 of these reports (44.8%) did not state 
the limitations of the application of grading systems to these tumor types. The number of reports 
that were graded with each grading system is listed in Table 8.  
 
4.3.5 Comments Section:  
Comments were provided in 363 reports (98.6%) with 275 reports (74.7%) giving general 
comments on the biologic behavior of MCT and 8 reports (2.2%) giving treatment 
recommendations. Additional immunohistochemistry (IHC) stains and diagnostics were 
performed or offered in 131 reports (35.6%) with the most common being c-KIT PCR (124 
reports, 33.7%), c-KIT IHC (106 reports, 28.8%), Ki-67 (95 reports, 25.8%), AgNOR (72 
reports, 19.6%) and PCNA (30 reports, 8.2%). The percent of reports that offered or performed 
additional stains and/or diagnostics for cutaneous MCT were 13.3% (6 reports) for grade 1, 
38.6% (78 reports) for grade 2, 40.5% (15 reports) for grade 3, 34.3% (71 reports) for low grade 
and 52.9% (27 reports) for high grade. For non-cutaneous tumors, additional IHC stains and 
diagnostics were performed or recommend in 20 reports (34.5%). A medical oncology 
consultation was recommended or offered in 71 reports (19.3%). References for the comments 
were provided in 296 reports (80.4%).  
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4.4 DISCUSSION 
The main purpose of a histopathology report is as a conveyor of information. Therefore, 
in order to evaluate a report, the important information that needs to be conveyed needs to be 
determined. Related to MCT, the clinician needs to know factors that influence prognosis and 
thus further treatment recommendations.. These factors include confirmation of tumor type, 
histopathologic grade of the MCT, information on the histologic margins and potentially 
recommendations for further diagnostic tests (Kamstock et al., 2011; Newman, 2003). This study 
found that for MCT, while the majority of these factors were presented within the histopathology 
reports, variation existed in the reporting especially related to histologic margins and grading of 
MCT. 
The majority of reports (356 reports, 96.7%) had a description of histologic margins; 
however, the way the histologic margins were reported varied. Almost a quarter of the reports 
did not describe both the lateral and deep histologic margins and only 60 reports (16.3%) 
described the direction of the closest histologic margin. While omission of this data may be due 
to lack of thorough evaluation, more likely the failure is related to incomplete reporting, vague 
wording of the report or an inability of the pathologist to completely evaluate these margins 
secondary to how the samples were submitted for evaluation. Many reports had presumptive 
wording such as the closest lateral margin was X mm. This statement fails to describe the deep 
margin as well as assumes that all other lateral histologic margins were measured but not 
reported specifically. Likewise, if a mass was incompletely resected, it was not consistent as to 
whether all histologic margins were described and to what level of detail. It is important to note 
that if the clinician did not identify the border of the cut margins of the sample in relation to the 
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patient, it would not be possible for a pathologist to accurately report all histologic margins in a 
way that could be related back to the patient.  
Information on all histologic margins, especially the distance of the closest neoplastic 
cells from the margin, which margins contain the closest tumor cells and the composition of the 
tissue composing the margin may effect the decision of whether or not to recommend a scar 
revision. For example, having tumor cells within 1mm of the margin may not be as concerning if 
the tissue composing the margin is fascia versus adipose tissue, which is generally thought to act 
as a poor barrier for tumor cell invasion. In this study, the tissue type composing the margin, the 
quality of the tissue composing the margin and a description of the neoplastic cells closest to the 
margin were all rarely recorded (40 reports/10.9%, 4 reports/1.1% and 2 reports/0.5% 
respectively). For MCT, identifying the tumor cells closest to the margin can pose a particular 
challenge given that clusters of mast cells within tissue or mast cells related to inflammation can 
be indistinguishable from neoplastic mast cells (Michels, Knapp, DeNicola, Glickman, & 
Bonney, 2002; Scarpa et al., 2012).  
Kamstock et al. recommended reporting histologic margins in objective measures and to 
avoid using subjective descriptors such as close or narrow (Kamstock et al., 2011). In this study, 
the histologic margins were quantified in centimeters or millimeters in 287 reports (78.0%) while 
subjective descriptors were used in 88 reports (23.9%). The use of subjective descriptors leaves 
room for interpretation, as the definition of “close” will vary between individuals. It has also 
been recommended to specifically state that a histologic margin is complete or incomplete 
(Kamstock et al., 2011), which was stated in 188 reports (51.1%). By stating complete versus 
incomplete histologic margins there is no room for misinterpretation. For MCT, it can be debated 
that the distance of the closest tumor cell to the histologic margins is unimportant as the width of 
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the histologic tumor free margin has not been associated with recurrence (Donnelly et al., 2015). 
Therefore, complete versus incomplete excision may be one of the main considerations when 
advising adjunctive therapy.  
The ability of the pathologist to interpret the histologic margins can be affected by the 
method of post-operative handing of the sample and the histologic processing. The most 
common method used for specimen trimming and histologic margin evaluation is the radial 
method for small or moderately sized masses (Kamstock et al., 2011). Using this method, an 
incredibly small portion of the margin (generally <0.1%) (Becker, 2007; Rapini, 1990) is 
actually evaluated while using other methods such as tangential sectioning or parallel slicing, a 
larger percentage of the margin can be evaluated (Kamstock et al., 2011). The radial method also 
assumes that tumors are symmetric/evenly distributed (Kamstock et al., 2011). Understanding 
which method was used for trimming and therefore the associated limitations is valuable 
information for the clinician when interpreting histologic margin results in relation to the true cut 
margins both for their patient as well as in research studies. In this study the method of sample 
trimming was only reported in 62 reports (16.8%). Another important aspect of histologic margin 
evaluation lies in the handling of the sample and post-operative marking of the margins. In this 
study, 123 (33.4%) of the reports had an indication that the margins were marked with ink or 
suture. While this may underestimate the number of specimens that were marked if this 
information was omitted from the report, it is likely that many specimens were unmarked. 
Without marking the borders of the sample, the orientation of the sample in relation to the animal 
cannot be determined and in some cases it can be difficult for the pathologist to determine the 
true cut borders or margins. The presence of a gross description within the reports would also be 
able to provide information related to how specimens were marked. 
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It was relatively uncommon for a gross description to be present, with only 97 reports 
(26.4%) containing this section and only 1 report contained images of the sample. The reports 
were also not standardized in how the dimensions of the sample were reported, with 43 reports 
measuring the sample in three dimensions, 23 in two dimensions and 21 reports in one 
dimension. The importance of the gross description is that it can help orient the clinician to the 
pathologist’s perspective. Images or a gross description can be especially useful when the case 
has been referred and the clinician using the report is not the clinician who initially removed the 
tumor. In relation to histologic margins, a gross description or image can also help report post-
surgical changes that occur in a specimen such as the degree of translation that occurred between 
the skin, subcutaneous tissue and fascial layers which may effect the pathologists ability to 
reliably access the histologic margins.  
For MCT, the biologic behavior of mucosal, subcutaneous and cutaneous tumors is 
different (Elliott et al., 2016; Newman et al., 2007; Thompson et al., 2011), which highlights the 
importance of the pathologist clearly indicating the tumors’ suspected origin on the 
histopathology report within the diagnosis. Overall, the vast majority of reports in this study 
clearly indicated the origin of the tumor in either the microscopic description and/or diagnosis 
with description of the tissue of origin only missing in 26 reports (7.1%). However, the grading 
of non-cutaneous versus cutaneous MCT was far more variable. For cutaneous MCT, a grade 
was given in 306 reports (98.7%) while for non-cutaneous MCT a grade was stated on 39 reports 
(67.2%). The primary grading systems used for grading MCT are the Patnaik and Kiupel systems 
(Kiupel et al., 2011; Patnaik et al., 1984). These systems were specifically developed for 
cutaneous MCT and have not been validated for non-cutaneous MCT (Elliott et al., 2016; 
Thompson et al., 2011). In subcutaneous MCT it has been shown that grade is not indicative of 
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behavior (Thompson et al., 2011). Therefore, while 13 of the 39 reports gave this as a limitation, 
26 of these reports (44.8% of the total reports for non-cutaneous MCT) used these grading 
systems and did not state the limitations of these grading systems related to non-cutaneous MCT. 
For clinicians that are unaware of this literature, failure to acknowledge these limitations could 
result in inappropriate monitoring or treatment recommendations for the patient.  
It has been recommended that both Patnaik and Kiupel grading systems be reported for 
cutaneous MCT ("VCS Oncology-Pathology Working Group MCT Subgroup Consensus on 
Grading Canine Cutaneous MCT," 2013). In this study, 23.6% of the reports did not comply with 
this recommendation. Using both of these systems has been recommended as each system has its 
strengths/weaknesses and both of these systems have been associated with prognosis in previous 
papers (Donnelly et al., 2015; Kiupel et al., 2011; Murphy et al., 2004; Patnaik et al., 1984; 
Schultheiss et al., 2011; Stefanello et al., 2015; Takeuchi et al., 2013). For the Patnaik system, 
the main concerns are 1) that the majority of tumors are intermediate in grade thereby 
diminishing its prognostic utility and 2) there is a significant amount of interobserver variation 
due to the subjective nature of the grading system (Northrup et al., 2005; Sabattini et al., 2015). 
The Kiupel system is more objective than the Patnaik system but it has not been evaluated as 
thoroughly. Recently, studies have been published comparing both grading systems (Sabattini et 
al., 2015; Stefanello et al., 2015; Takeuchi et al., 2013). Both Sabattini et al. and Takeuchi et al. 
evaluated the grading systems in relation to survival and both concluded the Kiupel system had 
superior prognostic value. Stefanello et al. evaluated the grading systems for prognosticating 
metastatic disease and concluded prognostication should not rely solely on grade but factor in the 
results of staging as even grade 1, grade 2, and low grade tumors had metastatic disease (5.8%, 
16.5% and 14.9% respectively). However, it was also noted that using both grading schemes 
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showed a difference in metastatic potential as grade 3/high grade tumors metastasized more 
frequently than grade 2/high grade tumors (49% vs. 15%) (Stefanello et al., 2015). Based on the 
results of this study, continued reporting of both grading schemes is supported.  
The history section contains important information for the pathologist as well as 
clinicians that may subsequently treat the case. The most common historical information 
provided was the location of the lesion (292 reports, 79.3%), suspected tumor type (219 reports, 
59.5%) and method of diagnosis of the suspected tumor type (122 reports, 33.2%). However, the 
size of the mass was only present in 75 reports (19.8%). Size has been shown to be an important 
prognostic indicator for MCT and is useful information for clinicians (Mullins et al., 2006). If a 
gross description from the pathologist is present, size may be indicated within that section of the 
report; however, the size of the mass may be decreased secondary to surgical removal and 
histopathologic processing (Risselada et al., 2015). Generally, it was noted that the history 
section was truncated, with the median number of words in the history being 17 (range 0-317). 
The brief histories supplied on the reports may be due to the history not being reported to the 
pathologist or the history being shortened or omitted by the pathologist. Historical information 
that is pertinent to diagnosis or prognosis is important both for the pathologist as well as for 
future clinicians reviewing the case and should ideally be included within the report. While 
adding this information may be beneficial, it needs to be weighed against time constraints and 
possible legal implications (e.g. accidental incorporation of incorrect information).  
Additional immunohistochemistry stains and/or PCR testing were recommended or 
offered in 131 reports (35.6%) with the most common being c-KIT PCR (124 reports, 33.7%), c-
KIT IHC (106 reports, 28.8%), Ki-67 (95 reports, 25.8%), AgNOR (72 reports, 19.6%) and 
PCNA (30 reports, 8.2%). Subjectively, certain diagnostic laboratories routinely offered or 
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recommended these tests suggesting that this is part of their protocol. Some 
immunohistochemistry stains and PCR testing have been associated with prognosis for MCT 
(Berlato et al., 2015; Costa Casagrande et al., 2015; Elston et al., 2009; Garrett, 2014; Kandefer-
Gola et al., 2015; Maglennon et al., 2008; Romansik et al., 2007; Scase et al., 2006; Seguin et al., 
2006; Takeuchi et al., 2013; van Lelyveld et al., 2015; Vascellari et al., 2013; Webster et al., 
2007), and the use of these tests in conjunction with histopathologic grade may help determine 
prognosis (Scase et al., 2006). The relatively low proportion of reports offering these additional 
immunohistochemistry stains and diagnostics shows a lack of general consensus on whether this 
should be included within the report. The discussion of which tests should be recommended or 
offered and by whom is beyond of the scope of this paper, however, this highlights an area of 
inconsistency that may be worthy of discussion.  
The main limitations of this paper are due to the subjective nature of evaluation of 
histopathology reports as well as the difficulty in obtaining a representative population of 
histopathology reports for the USA. The authors attempted to make the evaluation of the reports 
as objective as possible by making most categories a question of present versus absent. We also 
attempted to obtain reports from both academic and private practices from various geographic 
regions across the USA. However, those chosen to contribute reports were based on knowledge 
of individuals in the geographic regions and potential willingness to contribute reports, which 
may have introduced bias. Another source of bias could have been introduced in the assessment 
of subjective elements of the reports evaluated by two individuals (JKR and CF) potentially 
introducing interobserver variation in the interpretation of the reports. Since columns that were 
considered more subjective were evaluated by both individuals, the effects of interobserver are 
likely small, however interobserver error was not specifically assessed. Also, if the presence of 
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information was questionable, favor was generally given towards the information being present, 
rather than absent. Therefore, any bias would make the results presented within this paper more 
favorable towards the clinician and pathologist.  
 
4.5 CONCLUSIONS 
The study findings suggested that while histologic margins are generally reported, details 
about the margins (e.g. direction of the closest margin and tissues composing the margin) and 
consistency of how histologic margins are reported are generally lacking. While the majority of 
reports included both the Kiupel and Patnaik grading systems, about a quarter used only one 
grading system. Also, grade is often reported for non-cutaneous MCT without stating the 
appropriate limitations of using grading systems developed for cutaneous MCT. The 
histopathology report represents a vital communication between the pathologist and clinician. It 
is important for clinicians to improve communication with pathologists in the form of improved 
clinical history reporting and specimen marking. Likewise, this paper highlights the need for 
discussions on standardization of certain elements of the histopathology report especially in 
relation to grading and margin reporting.  
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CHAPTER 5 
FUTURE RESEARCH 
 For cutaneous tumors the best method of margin evaluation has yet to be determined. The 
topic of margin evaluation is deceptively complex as we are currently attempting to reconcile 
microscopic and macroscopic parameters. To complicate matters, the information being used has 
been derived with no standard protocols of methods or measurements.  
What may have the greatest impact (especially on veterinary medicine) on advancing the 
understanding of margins would be to develop standard protocols for reporting of margins (both 
surgical and histologic) as well as other factors suspected to be directly related to prognosis such 
as MCT grading. This would better allow information to be shared across institutions and make 
developing large multi-institutional prospective and retrospective studies more feasible. Several 
points related to histopathology reports were discussed in Chapter 4 and it seems important to 
define what an incomplete versus complete margin is specific to MCT. 
For MCT there is a large amount of data comparing margins and grade to outcome. 
Several studies have suggested that the planned surgical margins necessary to completely excise 
low grade tumors are less than the previously reported 3cm margins. One potential approach that 
could be used to help answer this question would be to perform a systematic review and plan 
prospective studies based on its results. Another possible direction would be to further evaluate 
the use of FNA as a proxy for grading and then plan surgical margins based off of FNA using 
small margins for suspected low grade tumors. A third possibility would be to plan a prospective 
study using shaved margins as this could be a better bridge to correlate surgical to histologic 
margins.  
	   66	  
 The most direct way to avoid the conundrum of histologic versus planned surgical 
margins is the concept of directly imaging of the tumor bed. Currently this is in the very early 
phases of use in both human and veterinary medicine, however, further studies on optical 
coherence imaging near-infrared fluorescence optical imaging are warranted as this is likely the 
future of margin evaluation.  
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CHAPTER 6 
FIGURES AND TABLES 
 
Figure 1—Photographs of the locations for the collection of skin samples from the head (A), hind limb 
(B), and lumbar region (C) of canine cadavers. In panel A, notice the placement for the 30-mm template 
on the left side of the head and the 10-mm template on the right side of the head.  
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Figure 2—Photographs illustrating steps involved in processing of skin samples obtained from canine 
cadavers. A—An elliptical area was drawn on the skin with an indelible marker; the black circle in the 
middle represented a tumor. A partial-thickness skin incision was made; length and width were measured 
at this stage (prior to excision [P1]). B—The incision was extended deeper into the skin until the fascial 
layer could be identified; depth of the sample was measured (P1) Ink dots of different colors were placed 
on the sample for orientation. C—A full-thickness incision was made on one side of the sample, and the 
sample was undermined beneath the fascial layer. Sutures were placed in the sample, and the sample was 
then excised. D—Excised skin samples were placed in neutral-buffered 10% formalin, and measurements 
were obtained after fixation for 24 hours (P2). E—Skin samples were embedded in paraffin. F—Slides of 
tissue samples were used for measurement of length and width (after histologic processing [P3]). 
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Table 1—Mean ± SD absolute length at various stages of processing* for 2 sizes of skin samples 
obtained from 3 anatomic locations of 15 canine cadavers.  
Sample size 
(mm) 
Anatomic 
location 
P1 length 
(mm) 
P2 length 
(mm) 
P3 length 
(mm) 
10  Hind limb 40.9 ± 1.4a 31.1 ± 2.3d 26.3 ± 2.4g 
10 Lumbar 40.0 ± 1.1b 33.1 ± 2.9e 26.7 ± 2.9h 
10 Head 40.9 ± 1.4c 35.3 ± 2.3f 27.9 ± 4.7i 
30 Hind limb 121.7 ± 3.2a 84.4 ± 4.5d 75.9 ± 2.2g 
30 Lumbar 120.5 ± 3.5b 96.7 ± 6.5e 85.3 ± 7.0h 
30 Head 121.1 ± 2.9c 102.9 ± 8.0f 92.1 ± 11.2i 
*Measurements were obtained prior to excision (P1), 24 to 48 hours after samples had been fixed 
in neutral-buffered 10% formalin for 24 hours (P2), and on slides prepared for histologic 
evaluation (P3).  
** Within a row, all values differ significantly (P<0.001). 
*** Within a column, values with different superscript letters differ significantly (P<0.001).  
 
Table 2—Mean ± SD absolute width at various stages of processing* for 2 sizes of skin samples 
obtained from 3 anatomic locations of 15 canine cadavers. 
Sample size 
(mm) 
Anatomic 
location 
P1 width 
(mm) 
P2 width 
(mm) 
P3 width 
(mm) 
10  Hind limb 18.9 ± 0.9a 17.9 ± 1.6d 15.5 ± 1.5g 
10 Lumbar 20.9 ± 1.1b 17.7 ± 0.9e 16.1 ± 1.6h 
10 Head 20.9 ± 1.0c 17.1 ± 0.9f 16.9 ± 1.8i 
30 Hind limb 59.5 ± 1.7a 49.3 ± 2.9d 47.2 ± 4.2g 
30 Lumbar 61.3 ± 1.8b 51.1 ± 2.1e 47.3 ± 3.5h 
30 Head 61.3 ± 1.6c 50.9 ± 3.4f 47.9 ± 4.1i 
See Table 1 for key.  
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Table 3—Mean ± SD SA at various stages of processing* for 2 sizes of skin samples obtained 
from 3 anatomic locations of 15 canine cadavers. 
Sample size 
(mm) 
Anatomic 
location P1 SA (mm2) P2 SA (mm2) 
10  Hind limb 492.2 ± 47.6 293.8 ± 46.4 
10 Lumbar 545.5 ± 67.4 337.2 ± 46.8 
10 Head 530.1 ± 54.9 349.5 ± 57.0 
30 Hind limb 4,145.1 ± 335.9 2,107.7 ± 160.3 
30 Lumbar 4,229.4 ± 314.0† 2,504.5 ± 360.4 
30 Head 4,197.3 ± 482.2 2,751.4 ± 437.8 
†Represents results for only 14 samples because the photograph for 1 sample was lost. See Table 
1 for remainder of key.  
 
Table 4—Mean ± SD percentage change in length between various stages of processing* for 2 
sizes of skin samples obtained from 3 anatomic locations of 15 canine cadavers.  
Sample 
size (mm) 
Anatomic 
location 
Change 
between P1 
and P2 (%)  
Change 
between P2 
and P3 (%) 
Change 
between P1 
and P3 (%) 
10 Hind limb  23.8 ± 4.3  15.3 ± 6.8 35.6 ± 4.8 
10 Lumbar 17.2 ± 6.8 19.5 ± 5.8 33.3 ± 7.0 
10 Head 13.7 ± 4.8  18.7 ± 8.6 35.6 ± 4.8 
30 Hind limb  30.6 ± 3.9 10.1 ± 4.8 37.7 ± 2.0 
30 Lumbar 19.7 ± 5.5 11.9 ± 3.7  29.3 ± 5.3 
30 Head 15.1 ± 6.0 10.7 ± 5.9 24.0 ± 8.4 
 
Percentage change was calculated by use of the following equations: change between P1 and P2 
= ([P1 measurement – P2 measurement]/P1 measurement) X 100, change between P2 and P3 = 
([P2 measurement – P3 measurement]/P2 measurement) X 100, and change between P1 and P3 = 
([P1 measurement – P3 measurement]/P1 measurement) X 100. See Table 1 for remainder of 
key. 
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Table 5—Mean ± SD percentage change in width between various stages of processing* for 2 
sizes of skin samples obtained from 3 anatomic locations of 15 canine cadavers. 
 
Sample 
size (mm) 
Anatomic 
location 
Change 
between P1 
and P2 (%) 
Change 
between P2 
and P3 (%) 
Change 
between P1 
and P3 (%)  
10 Hind limb  9.5 ± 3.9 9.4 ± 6.7 18.0 ± 6.9 
10 Lumbar 15.1 ± 6.0 8.1 ± 7.5 22.6 ± 7.9 
10 Head 14.3 ± 7.6  5.1 ± 7.3 18.7 ± 9.4 
30 Hind limb  17.1 ± 4.4  4.2 ± 8.8  20.6 ± 8.4 
30 Lumbar 16.6 ± 3.7 7.5 ± 4.9 22.8 ± 5.9 
30 Head 17.1 ± 5.0 5.8 ± 5.2 21.8 ± 6.7 
See Tables 1 and 4 for key. 
 
Table 6: Distribution of the states by region of the United States of America based on the United 
States Census Bureau.  
Region of the United States States within Region 
Northeast ME, NH, VT, NY, MA, CT, RI, NJ, PA, DE, MD, WV, VA 
South KY, NC, TN, SC, GA, AL, MS, FL, TX, OK, AR, LA 
Midwest ND, MN, WS, MI, SD, IA, IL, IN, OH, NE, KS, MO 
West WA, OR, ID, MT, WY, AK, CA, NV, UT, CO, AZ, NM, HI 
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Table 7: Information evaluated within each histopathology report.  
Report section 
 
Information evaluated within each section Answer format 
Signalment Age at the time of the report 
Breed 
Sex  
 
Year or missing 
Breed or missing 
Sex or missing 
Clinical history Clinical history present 
Number of words† 
Adequate history‡, § 
Age at diagnosis 
Location 
Adequate description 
Number of masses,  
Mass size 
Mass growth rate 
Suspected tumor type 
Method diagnosis 
Expected surgical margin 
Marked margins (sutured or inked)*, § 
Current medications 
 
Yes or no 
Number or missing 
Remaining information 
evaluated as yes, no or 
missing if a clinical history 
was not present 
Gross description Gross description present 
Tumor size  
Location 
 
Yes or no 
3D, 2D, 1D or missing 
Yes or no 
Microscopic 
description 
Mitotic index 
Number of mitotic figures per HPF 
Tissue of origin§ 
 
Yes or no 
Yes or no 
Subcutaneous, cutaneous, 
or non-cutaneous 
 
Diagnosis/MCT 
grading system 
Grading system used 
 
If non-cutaneous/subcutaneous were 
limitations stated§ 
Grade given 
Both, Kuipel, Patnaik or 
none 
Yes, no 
 
High, low or 1,2,3 	  	  	  	  	  	  	  	  	  
	   73	  
Table	  7	  (cont.)	  
	  
Margin evaluation Margins reported 
Description of neoplastic cells closest to 
the margin	  § 
All margins described§ 
Metric measurements used 
Direction of closest lateral margin § 
Tissue composing the margin§ 
Margin tissue quality§ 
Trimming method§ 
Subjective descriptors used§ 
Margins stated complete or incomplete 
 
Yes or no 
Remaining information 
evaluated as yes, no or 
missing if margins were 
not reported 
 
 
Comments  Comments section present 
Additional diagnostics recommend or 
performed  
If applicable the diagnostic recommended 
was recorded 
Comments on biologic behavior  
 
Oncologist consultation recommended  
 
References 
 
Yes, no 
Yes, no, missing if no 
comment section 
AgNOR, PCNA, c-kit IHC, 
c-kit PCR, ki-67, other 
Yes, no, missing if no 
comment section 
Yes, no, missing if no 
comment section 
Yes, no, NA  
 
* If margins were inked or marked within the gross description this was included within this 
category.  † MCT and FNA considered 1 word for count purposes.  ‡ Subjectively adequate history was defined as yes if 3 or more of the specific pieces of 
information listed within this section below adequate history was present. § Columns evaluated by both JKR and CF. For information that was considered more subjective 
in nature reports were evaluated by both evaluators and if a concern arose LES was consulted.  
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Table 8: Grading systems used for reporting the grade of MCT that were cutaneous and non-
cutaneous in origin. The cutaneous category contains all tumors that were reported as cutaneous 
in origin or that were not specified and presumed to be cutaneous based on the report.  
MCT tissue of origin Both Kiupel Patnaik No grade 
Cutaneous 237 (76.5%) 22 (7.1%) 47 (15.2%) 4 (1.3%) 
Non-cutaneous 
All reports 28 (48.3%) 3 (5.2%) 8 (13.8%) 19 (32.8%) 
Non-cutaneous  
Stating grading limitations* 9 (32.1%) 2 (66.7%) 2 (25%) 10 (52.6%) 
 
* For non-cutaneous MCT no grade should be given, as these grading systems do not apply to 
non-cutaneous MCT. These numbers reflect the number of reports that stated this limitation with 
the percentage being of the total number of reports within the grading category for non-
cutaneous tumors. 
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